name,smiles,stress_type,reagent,severity,temp_bin,duration_bin,strength_bin,temperature_mean,duration_mean,strength_mean,pH_mean,initial_api_percent,initial_degradant_percent,true_api_loss_percent,true_degradant_percent,model_predicted_api_loss_percent,model_predicted_degradant_percent,avg_mass,logP,logS,PSA,HBD,HBA,rot_bonds,rings,pKa_acid,pKa_base
Nitric Oxide,[N]=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,11.0,5.5,7.27,3.07,30.0061,-0.35,,34.14,0.0,1.0,0.0,0.0,,-2.9
L-Glutamine,N[C@@H](CCC(N)=O)C(O)=O,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,12.0,5.0,12.46,5.3,146.1445,-4.0,-0.17,106.41,3.0,4.0,4.0,0.0,2.15,9.31
Trospium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,3.5,5.24,2.11,392.518,-0.5,-6.8,46.53,1.0,2.0,5.0,5.0,11.05,-4.5
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,5.0,2.0,5.67,2.38,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Betamethasone,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,15.0,6.0,12.36,5.26,392.4611,1.68,-3.9,94.83,3.0,5.0,2.0,4.0,12.42,-3.3
Oxyphencyclimine,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,4.5,15.95,6.82,344.4479,2.62,-3.8,62.13,1.0,4.0,6.0,3.0,11.54,9.27
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,2.0,1.0,5.9,2.49,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Vitamin E,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,3.0,0.8,3.28,1.26,430.7061,10.51,-7.8,29.46,1.0,2.0,12.0,2.0,10.8,-4.9
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,3.0,7.26,3.06,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Timolol,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,8.0,4.0,6.78,2.84,316.42,1.34,-3.1,79.74,2.0,7.0,7.0,2.0,14.08,9.76
Mazindol,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,5.0,2.5,6.68,2.78,284.74,3.44,-3.3,35.83,1.0,3.0,1.0,4.0,11.61,3.86
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,5.0,1.5,5.2,2.18,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Ramipril,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.0,0.5,1.97,0.82,416.5106,1.47,-4.0,95.94,2.0,5.0,10.0,3.0,3.75,5.2
Adenosine phosphate,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,5.5,2.0,7.79,3.29,347.2212,-4.7,,186.07,5.0,10.0,4.0,3.0,1.23,3.92
Calcifediol,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,7.0,3.5,6.11,2.53,400.6371,5.65,-5.3,40.46,2.0,2.0,6.0,3.0,18.38,-0.98
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,12.0,4.5,14.16,6.04,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Dydrogesterone,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.2,2.6,1.05,312.4458,3.79,-4.8,34.14,0.0,2.0,1.0,4.0,19.4,-4.8
Ceftazidime,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,3.0,7.52,3.16,546.576,-4.2,-5.0,191.22,3.0,10.0,9.0,4.0,2.42,4.02
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.0,0.5,1.87,0.74,321.158,3.53,-4.3,61.69,2.0,3.0,1.0,3.0,10.61,-2.2
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,8.0,3.5,5.73,2.4,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Allopurinol,OC1=NC=NC2=C1C=NN2,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,5.0,14.31,6.11,136.1115,0.031,-0.79,74.69,2.0,4.0,0.0,2.0,8.47,1.25
Ramipril,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,10.0,4.0,13.91,5.93,416.5106,1.47,-4.0,95.94,2.0,5.0,10.0,3.0,3.75,5.2
Zanamivir,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,14.0,4.0,12.73,5.42,332.3098,-5.8,-1.7,200.72,7.0,10.0,6.0,1.0,3.06,11.93
Oseltamivir,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.64,1.52,312.4045,1.16,-2.7,90.65,2.0,4.0,8.0,1.0,14.03,9.31
Chloroquine,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,2.0,2.84,1.11,319.872,3.93,-4.3,28.16,1.0,3.0,8.0,2.0,,10.32
Esmolol,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.5,4.2,9.23,3.91,295.374,1.82,-3.3,67.79,2.0,4.0,10.0,1.0,14.09,9.67
alpha-Linolenic acid,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.5,0.9,2.74,1.12,278.4296,6.06,-6.0,37.3,1.0,2.0,13.0,0.0,4.99,
Fosinopril,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,4.0,11.8,5.02,563.672,5.62,-5.8,110.21,1.0,5.0,15.0,3.0,3.87,-4.4
Fondaparinux,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,2.5,7.45,3.14,1508.263,-10.0,-2.3,805.48,19.0,44.0,27.0,5.0,-3.0,
Dydrogesterone,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,4.0,11.29,4.8,312.4458,3.79,-4.8,34.14,0.0,2.0,1.0,4.0,19.4,-4.8
Bendroflumethiazide,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.5,3.62,1.5,421.415,1.7,-3.3,118.36,3.0,5.0,4.0,3.0,9.04,-3.1
Levocarnitine,C[N+](C)(C)C[C@H](O)CC([O-])=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,10.0,4.0,9.85,4.15,161.1989,-4.9,-1.6,60.36,1.0,3.0,4.0,0.0,4.2,-3.6
Zafirlukast,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,15.0,7.5,12.18,5.18,575.675,6.4,-5.8,115.73,2.0,6.0,8.0,5.0,4.29,-1.1
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,12.0,3.5,10.4,4.39,297.415,4.2,-5.0,21.26,1.0,2.0,6.0,3.0,,9.7
Fondaparinux,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,12.0,5.0,9.48,4.01,1508.263,-10.0,-2.3,805.48,19.0,44.0,27.0,5.0,-3.0,
Nitric Oxide,[N]=O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,15.0,7.0,3.83,1.61,30.0061,-0.35,,34.14,0.0,1.0,0.0,0.0,,-2.9
Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,3.4,1.42,780.9385,2.37,-3.8,203.06,6.0,13.0,7.0,8.0,7.15,-3.0
Sulfadiazine,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,12.0,4.0,11.79,5.01,250.277,0.39,-2.6,97.97,2.0,5.0,2.0,2.0,6.99,2.01
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,6.0,16.3,6.97,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Vitamin E,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,2.0,0.8,2.93,1.11,430.7061,10.51,-7.8,29.46,1.0,2.0,12.0,2.0,10.8,-4.9
Pyrazinamide,NC(=O)C1=NC=CN=C1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,1.5,4.68,1.95,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,1.5,5.22,2.18,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Oseltamivir,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,6.18,2.6,312.4045,1.16,-2.7,90.65,2.0,4.0,8.0,1.0,14.03,9.31
Cyproheptadine,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,4.0,7.3,3.07,287.3981,4.38,-4.3,3.24,0.0,1.0,0.0,4.0,,8.05
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,14.0,4.5,16.38,7.01,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Beclomethasone dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,6.0,3.0,5.05,2.1,521.042,4.43,-5.4,106.97,1.0,5.0,8.0,4.0,13.85,-3.3
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,5.0,2.5,5.63,2.34,162.2316,1.16,-0.24,16.13,0.0,2.0,1.0,2.0,,8.58
Cyproheptadine,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,2.0,4.49,1.86,287.3981,4.38,-4.3,3.24,0.0,1.0,0.0,4.0,,8.05
L-Glutamine,N[C@@H](CCC(N)=O)C(O)=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.0,5.46,2.3,146.1445,-4.0,-0.17,106.41,3.0,4.0,4.0,0.0,2.15,9.31
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,7.0,3.0,8.27,3.49,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
Nitric Oxide,[N]=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,13.0,6.5,8.93,3.77,30.0061,-0.35,,34.14,0.0,1.0,0.0,0.0,,-2.9
Reboxetine,[H][C@@]1(CNCCO1)[C@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,1.0,2.11,0.88,313.397,3.28,-4.2,39.72,1.0,4.0,6.0,3.0,,7.91
Sucralfate,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,5.0,2.0,3.75,1.57,1558.67,-5.9,-3.3,772.17,16.0,35.0,37.0,2.0,13.53,-3.0
Dydrogesterone,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,12.0,5.0,11.55,4.91,312.4458,3.79,-4.8,34.14,0.0,2.0,1.0,4.0,19.4,-4.8
Trospium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,1.5,0.56,392.518,-0.5,-6.8,46.53,1.0,2.0,5.0,5.0,11.05,-4.5
Dexrazoxane,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,9.0,3.5,9.46,4.01,268.2691,-2.7,-1.4,98.82,2.0,6.0,3.0,2.0,11.2,3.2
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,2.0,6.9,2.91,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Thiethylperazine,CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,7.0,2.5,7.72,3.21,399.616,4.66,-4.9,9.72,0.0,3.0,6.0,4.0,,8.0
Leucine,CC(C)C[C@H](N)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,3.0,1.0,4.48,1.86,131.1729,-1.6,-0.27,63.32,2.0,3.0,3.0,0.0,2.79,9.52
Loratadine,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,9.0,3.0,8.26,3.48,382.883,4.55,-4.5,42.43,0.0,2.0,2.0,4.0,,4.33
Mephenytoin,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,12.0,5.0,12.4,5.28,218.2518,1.67,-2.4,49.41,1.0,2.0,2.0,2.0,11.09,-8.1
Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.0,5.25,2.2,780.9385,2.37,-3.8,203.06,6.0,13.0,7.0,8.0,7.15,-3.0
Pentagastrin,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.5,2.98,1.24,767.9,1.05,-5.5,250.91,8.0,8.0,22.0,3.0,4.0,
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,17.0,7.0,13.99,5.97,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Calcifediol,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,4.0,2.0,5.02,2.07,400.6371,5.65,-5.3,40.46,2.0,2.0,6.0,3.0,18.38,-0.98
Carmustine,ClCCNC(=O)N(CCCl)N=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,2.5,7.04,2.95,214.05,1.02,-2.2,61.77,1.0,2.0,5.0,0.0,13.36,-5.3
Fluticasone propionate,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.16,0.9,500.571,3.72,-4.6,80.67,1.0,4.0,6.0,4.0,13.61,-3.4
Benzatropine,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,5.0,2.5,5.3,2.2,307.4293,4.19,-5.4,12.47,0.0,2.0,4.0,4.0,,9.54
Beclomethasone dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,12.0,6.0,11.88,5.05,521.042,4.43,-5.4,106.97,1.0,5.0,8.0,4.0,13.85,-3.3
Amodiaquine,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,0.7,1.86,0.72,355.861,3.8,-4.6,48.39,2.0,4.0,6.0,3.0,9.1,10.17
Zanamivir,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,1.5,5.46,2.3,332.3098,-5.8,-1.7,200.72,7.0,10.0,6.0,1.0,3.06,11.93
Fluticasone propionate,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.0,3.58,1.49,500.571,3.72,-4.6,80.67,1.0,4.0,6.0,4.0,13.61,-3.4
Vitamin A,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,1.0,4.69,1.96,286.4516,4.69,-4.6,20.23,1.0,1.0,5.0,1.0,16.44,-2.2
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,9.0,4.5,14.29,6.09,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,1.8,5.38,2.26,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Cystine,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,5.0,16.15,6.9,240.3,-5.9,-1.2,126.64,4.0,6.0,7.0,0.0,1.56,9.34
Carmustine,ClCCNC(=O)N(CCCl)N=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,17.0,6.0,12.11,5.15,214.05,1.02,-2.2,61.77,1.0,2.0,5.0,0.0,13.36,-5.3
Zafirlukast,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,6.0,3.0,5.07,2.11,575.675,6.4,-5.8,115.73,2.0,6.0,8.0,5.0,4.29,-1.1
Biotin,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,0.5,2.09,0.86,244.311,0.32,-2.3,78.43,3.0,3.0,5.0,2.0,4.4,-1.9
Bendroflumethiazide,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.0,4.8,2.01,421.415,1.7,-3.3,118.36,3.0,5.0,4.0,3.0,9.04,-3.1
Tranexamic acid,NC[C@H]1CC[C@@H](CC1)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,0.8,2.67,1.09,157.2102,-1.6,-0.94,63.32,2.0,3.0,2.0,1.0,4.56,10.22
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,5.0,2.0,7.04,2.93,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Asparagine,N[C@@H](CC(N)=O)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,2.0,0.8,4.95,2.08,132.1179,-4.3,0.1,106.41,3.0,4.0,3.0,0.0,2.0,8.43
Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,10.0,5.0,13.07,5.56,307.282,2.12,-4.6,111.43,1.0,5.0,5.0,2.0,10.62,-4.2
Vitamin A,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,2.0,7.14,3.01,286.4516,4.69,-4.6,20.23,1.0,1.0,5.0,1.0,16.44,-2.2
Gadoteridol,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,1.5,4.88,2.05,558.68,-6.8,-1.8,153.58,1.0,11.0,8.0,1.0,1.46,8.3
Dihydroergotamine,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,7.0,3.0,5.28,2.21,583.6774,2.71,-3.4,118.21,3.0,6.0,4.0,8.0,9.71,8.39
Oxytetracycline,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,3.0,7.41,3.13,460.434,-4.5,-2.5,201.85,7.0,10.0,2.0,4.0,2.84,7.41
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,3.0,1.5,5.16,2.16,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Carbidopa,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,10.0,4.0,8.63,3.65,226.2292,-1.2,-1.8,115.81,5.0,6.0,4.0,1.0,2.35,5.66
Oxiconazole,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,12.0,6.0,11.82,5.0,429.12,5.84,-5.4,39.41,0.0,3.0,6.0,3.0,,6.74
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,5.0,1.0,5.63,2.36,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Levocarnitine,C[N+](C)(C)C[C@H](O)CC([O-])=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,7.0,2.5,6.6,2.71,161.1989,-4.9,-1.6,60.36,1.0,3.0,4.0,0.0,4.2,-3.6
Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,2.0,6.42,2.67,307.282,2.12,-4.6,111.43,1.0,5.0,5.0,2.0,10.62,-4.2
Nabilone,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,10.0,5.0,7.91,3.31,372.5408,6.36,-5.9,46.53,1.0,3.0,6.0,3.0,9.33,-4.9
Carmustine,ClCCNC(=O)N(CCCl)N=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,2.87,1.18,214.05,1.02,-2.2,61.77,1.0,2.0,5.0,0.0,13.36,-5.3
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,5.0,12.12,5.16,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Pyrazinamide,NC(=O)C1=NC=CN=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,5.5,2.2,5.09,2.13,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Metolazone,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.5,1.7,3.32,1.36,365.835,2.94,-4.0,92.5,2.0,4.0,2.0,3.0,9.54,-1.6
Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.5,5.15,2.16,780.9385,2.37,-3.8,203.06,6.0,13.0,7.0,8.0,7.15,-3.0
Zafirlukast,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,3.5,5.57,2.33,575.675,6.4,-5.8,115.73,2.0,6.0,8.0,5.0,4.29,-1.1
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,1.5,5.76,2.35,297.415,4.2,-5.0,21.26,1.0,2.0,6.0,3.0,,9.7
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,13.0,5.0,9.26,3.92,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Mephenytoin,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,1.5,0.6,2.15,0.9,218.2518,1.67,-2.4,49.41,1.0,2.0,2.0,2.0,11.09,-8.1
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,5.67,2.35,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Ceftazidime,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.5,5.07,2.11,546.576,-4.2,-5.0,191.22,3.0,10.0,9.0,4.0,2.42,4.02
Adenosine phosphate,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.5,2.0,7.0,2.95,347.2212,-4.7,,186.07,5.0,10.0,4.0,3.0,1.23,3.92
Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,5.0,2.0,5.78,2.41,226.2722,1.89,-2.4,75.27,2.0,3.0,4.0,1.0,7.48,
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.8,2.06,0.87,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Acarbose,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,16.0,6.0,12.45,5.3,645.608,-8.3,-0.78,329.01,14.0,19.0,13.0,3.0,11.83,7.03
L-Glutamine,N[C@@H](CCC(N)=O)C(O)=O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,4.0,7.97,3.37,146.1445,-4.0,-0.17,106.41,3.0,4.0,4.0,0.0,2.15,9.31
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,2.5,5.51,2.3,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Fenoprofen,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,20.0,9.0,16.13,6.9,242.2699,3.65,-3.5,46.53,1.0,2.0,4.0,2.0,3.96,-3.7
Acetyldigitoxin,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,1.96,0.82,806.9757,4.04,-4.8,188.9,4.0,12.0,9.0,8.0,7.18,0.24
Dydrogesterone,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,8.0,3.5,7.88,3.32,312.4458,3.79,-4.8,34.14,0.0,2.0,1.0,4.0,19.4,-4.8
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,4.0,7.38,3.1,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Lymecycline,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)=C(O)[C@H]2N(C)C,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,12.0,5.0,14.1,6.02,602.6328,-7.1,-2.7,242.98,9.0,13.0,10.0,4.0,2.51,9.77
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.5,3.67,1.54,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.5,2.1,0.88,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Asparagine,N[C@@H](CC(N)=O)C(O)=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,2.0,0.7,5.47,2.3,132.1179,-4.3,0.1,106.41,3.0,4.0,3.0,0.0,2.0,8.43
Secobarbital,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.8,1.93,0.8,238.2829,2.03,-2.3,75.27,2.0,3.0,5.0,1.0,7.48,
Timolol,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,14.0,7.0,13.32,5.67,316.42,1.34,-3.1,79.74,2.0,7.0,7.0,2.0,14.08,9.76
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.0,6.22,2.62,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Zafirlukast,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,5.96,2.49,575.675,6.4,-5.8,115.73,2.0,6.0,8.0,5.0,4.29,-1.1
Zafirlukast,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,9.0,4.5,8.39,3.54,575.675,6.4,-5.8,115.73,2.0,6.0,8.0,5.0,4.29,-1.1
Fosinopril,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,9.0,4.5,6.67,2.8,563.672,5.62,-5.8,110.21,1.0,5.0,15.0,3.0,3.87,-4.4
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,7.0,2.5,8.78,3.71,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,5.0,11.01,4.66,321.158,3.53,-4.3,61.69,2.0,3.0,1.0,3.0,10.61,-2.2
Ipratropium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,3.0,1.0,4.11,1.62,332.463,-1.8,-5.5,46.53,1.0,2.0,6.0,3.0,15.15,-2.7
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,1.83,0.74,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Methyclothiazide,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,2.85,1.16,360.237,0.53,-2.6,109.57,2.0,5.0,2.0,2.0,9.29,-3.4
Beclomethasone dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,2.0,3.46,1.43,521.042,4.43,-5.4,106.97,1.0,5.0,8.0,4.0,13.85,-3.3
Oxaliplatin,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,4.0,13.61,5.79,397.294,-0.47,-1.2,85.82,0.0,0.0,0.0,3.0,,
Loratadine,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,10.0,4.0,8.9,3.76,382.883,4.55,-4.5,42.43,0.0,2.0,2.0,4.0,,4.33
Carbidopa,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.0,5.31,2.22,226.2292,-1.2,-1.8,115.81,5.0,6.0,4.0,1.0,2.35,5.66
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,12.0,4.5,12.61,5.37,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Amodiaquine,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,1.7,3.99,1.6,355.861,3.8,-4.6,48.39,2.0,4.0,6.0,3.0,9.1,10.17
Ethambutol,CC[C@@H](CO)NCCN[C@@H](CC)CO,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.5,3.4,1.41,204.3098,-0.059,,64.52,4.0,4.0,9.0,0.0,14.82,9.55
Vitamin E,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,2.0,0.5,2.18,0.81,430.7061,10.51,-7.8,29.46,1.0,2.0,12.0,2.0,10.8,-4.9
Fluorouracil,FC1=CNC(=O)NC1=O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,6.0,3.0,6.89,2.87,130.0772,-0.66,-1.4,58.2,2.0,2.0,0.0,1.0,7.18,-8.0
Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,5.0,2.0,7.33,3.08,226.2722,1.89,-2.4,75.27,2.0,3.0,4.0,1.0,7.48,
Mazindol,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,2.0,1.0,3.33,1.35,284.74,3.44,-3.3,35.83,1.0,3.0,1.0,4.0,11.61,3.86
Zafirlukast,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,2.0,3.34,1.38,575.675,6.4,-5.8,115.73,2.0,6.0,8.0,5.0,4.29,-1.1
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,4.0,2.0,7.1,2.97,162.2316,1.16,-0.24,16.13,0.0,2.0,1.0,2.0,,8.58
Reboxetine,[H][C@@]1(CNCCO1)[C@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,3.0,5.2,2.17,313.397,3.28,-4.2,39.72,1.0,4.0,6.0,3.0,,7.91
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,15.0,7.5,11.96,5.09,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Fondaparinux,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,8.0,3.0,7.15,3.02,1508.263,-10.0,-2.3,805.48,19.0,44.0,27.0,5.0,-3.0,
Leucine,CC(C)C[C@H](N)C(O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,6.0,2.0,6.82,2.86,131.1729,-1.6,-0.27,63.32,2.0,3.0,3.0,0.0,2.79,9.52
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.0,3.0,9.4,3.98,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,16.0,5.0,14.05,5.99,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,6.0,16.54,7.08,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Vitamin A,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,5.0,1.2,5.11,2.14,286.4516,4.69,-4.6,20.23,1.0,1.0,5.0,1.0,16.44,-2.2
Oxiconazole,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,2.0,1.0,4.35,1.74,429.12,5.84,-5.4,39.41,0.0,3.0,6.0,3.0,,6.74
Secobarbital,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,8.0,3.0,7.08,2.98,238.2829,2.03,-2.3,75.27,2.0,3.0,5.0,1.0,7.48,
Biotin,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,3.0,1.0,5.11,2.12,244.311,0.32,-2.3,78.43,3.0,3.0,5.0,2.0,4.4,-1.9
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,14.0,7.0,12.56,5.35,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,2.5,7.18,3.03,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Methyclothiazide,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.5,1.97,0.8,360.237,0.53,-2.6,109.57,2.0,5.0,2.0,2.0,9.29,-3.4
Bendroflumethiazide,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,2.5,7.76,3.27,421.415,1.7,-3.3,118.36,3.0,5.0,4.0,3.0,9.04,-3.1
Fluorouracil,FC1=CNC(=O)NC1=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,12.0,6.0,11.27,4.78,130.0772,-0.66,-1.4,58.2,2.0,2.0,0.0,1.0,7.18,-8.0
Sulfadiazine,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,10.0,3.0,12.05,5.12,250.277,0.39,-2.6,97.97,2.0,5.0,2.0,2.0,6.99,2.01
Oseltamivir,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,2.0,7.04,2.97,312.4045,1.16,-2.7,90.65,2.0,4.0,8.0,1.0,14.03,9.31
Lymecycline,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)=C(O)[C@H]2N(C)C,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,6.0,16.49,7.05,602.6328,-7.1,-2.7,242.98,9.0,13.0,10.0,4.0,2.51,9.77
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,5.0,1.0,5.13,2.14,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Nabilone,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,12.0,6.0,7.29,3.04,372.5408,6.36,-5.9,46.53,1.0,3.0,6.0,3.0,9.33,-4.9
Indecainide,CC(C)NCCCC1(C(N)=O)C2=CC=CC=C2C2=CC=CC=C12,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.5,3.36,1.38,308.4174,3.26,-5.5,55.12,2.0,2.0,6.0,3.0,16.51,10.4
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.5,3.46,1.44,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,4.0,12.35,5.26,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Betamethasone,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.8,1.97,0.82,392.4611,1.68,-3.9,94.83,3.0,5.0,2.0,4.0,12.42,-3.3
Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.0,4.43,1.81,307.282,2.12,-4.6,111.43,1.0,5.0,5.0,2.0,10.62,-4.2
Baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,7.0,3.5,4.98,2.06,213.661,-0.78,-2.5,63.32,2.0,3.0,4.0,1.0,3.89,9.79
Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.0,5.68,2.35,307.282,2.12,-4.6,111.43,1.0,5.0,5.0,2.0,10.62,-4.2
Sulfadiazine,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.0,5.13,2.13,250.277,0.39,-2.6,97.97,2.0,5.0,2.0,2.0,6.99,2.01
Benzatropine,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,2.0,4.41,1.82,307.4293,4.19,-5.4,12.47,0.0,2.0,4.0,4.0,,9.54
Codeine,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,11.0,5.0,8.5,3.59,299.3642,1.34,-2.7,41.93,1.0,4.0,1.0,5.0,13.78,9.19
Carmustine,ClCCNC(=O)N(CCCl)N=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,9.0,3.0,8.37,3.53,214.05,1.02,-2.2,61.77,1.0,2.0,5.0,0.0,13.36,-5.3
Adenosine phosphate,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.5,0.5,2.03,0.85,347.2212,-4.7,,186.07,5.0,10.0,4.0,3.0,1.23,3.92
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.5,5.29,2.22,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Nimodipine,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,7.0,3.5,7.09,2.99,418.4403,2.54,-4.5,117.0,1.0,6.0,10.0,2.0,16.96,-4.1
Baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,9.0,4.5,6.61,2.76,213.661,-0.78,-2.5,63.32,2.0,3.0,4.0,1.0,3.89,9.79
Cinnarizine,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,13.0,5.5,11.82,5.03,368.524,5.88,,6.48,0.0,2.0,6.0,4.0,,8.1
Carmustine,ClCCNC(=O)N(CCCl)N=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,8.0,2.5,5.97,2.49,214.05,1.02,-2.2,61.77,1.0,2.0,5.0,0.0,13.36,-5.3
Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,1.0,0.5,2.05,0.82,307.282,2.12,-4.6,111.43,1.0,5.0,5.0,2.0,10.62,-4.2
Pyrazinamide,NC(=O)C1=NC=CN=C1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,3.36,1.39,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,0.8,2.94,1.23,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
Methyclothiazide,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.5,3.33,1.36,360.237,0.53,-2.6,109.57,2.0,5.0,2.0,2.0,9.29,-3.4
Fluorouracil,FC1=CNC(=O)NC1=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,1.0,1.97,0.78,130.0772,-0.66,-1.4,58.2,2.0,2.0,0.0,1.0,7.18,-8.0
Cystine,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,2.89,1.19,240.3,-5.9,-1.2,126.64,4.0,6.0,7.0,0.0,1.56,9.34
Esmolol,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,6.5,3.3,6.93,2.92,295.374,1.82,-3.3,67.79,2.0,4.0,10.0,1.0,14.09,9.67
Cyproheptadine,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,5.0,1.8,6.82,2.86,287.3981,4.38,-4.3,3.24,0.0,1.0,0.0,4.0,,8.05
Cefdinir,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.0,5.1,2.12,395.414,-0.89,-3.6,158.21,4.0,8.0,5.0,3.0,2.73,3.61
Carbidopa,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.18,0.91,226.2292,-1.2,-1.8,115.81,5.0,6.0,4.0,1.0,2.35,5.66
Zanamivir,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,6.0,1.8,7.18,3.03,332.3098,-5.8,-1.7,200.72,7.0,10.0,6.0,1.0,3.06,11.93
Nitisinone,[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,12.0,4.5,9.38,3.97,329.2281,3.13,-4.6,94.35,0.0,5.0,4.0,2.0,7.44,-7.3
Secobarbital,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,3.33,1.38,238.2829,2.03,-2.3,75.27,2.0,3.0,5.0,1.0,7.48,
Biotin,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,3.0,5.51,2.3,244.311,0.32,-2.3,78.43,3.0,3.0,5.0,2.0,4.4,-1.9
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.59,1.5,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Secobarbital,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,2.5,7.58,3.2,238.2829,2.03,-2.3,75.27,2.0,3.0,5.0,1.0,7.48,
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,2.0,7.16,3.01,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Adenosine phosphate,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,0.7,2.2,0.92,347.2212,-4.7,,186.07,5.0,10.0,4.0,3.0,1.23,3.92
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,12.0,5.0,12.03,5.12,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
Lutein,C\C(\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,2.0,3.44,1.43,568.886,8.55,-5.9,40.46,2.0,2.0,10.0,2.0,18.22,-0.91
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,5.0,11.34,4.82,162.2316,1.16,-0.24,16.13,0.0,2.0,1.0,2.0,,8.58
Cinnarizine,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,0.8,2.71,1.1,368.524,5.88,,6.48,0.0,2.0,6.0,4.0,,8.1
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.0,4.92,2.06,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,7.0,3.0,8.49,3.57,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Lysine,NCCCC[C@H](N)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,3.4,1.41,146.1876,-3.2,-0.14,89.34,3.0,4.0,5.0,0.0,2.74,10.29
Cinnarizine,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,18.0,7.0,13.35,5.69,368.524,5.88,,6.48,0.0,2.0,6.0,4.0,,8.1
Metolazone,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,3.5,6.98,2.93,365.835,2.94,-4.0,92.5,2.0,4.0,2.0,3.0,9.54,-1.6
Secobarbital,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.5,3.48,1.44,238.2829,2.03,-2.3,75.27,2.0,3.0,5.0,1.0,7.48,
Atomoxetine,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,4.0,2.0,5.73,2.38,255.3547,3.81,-4.8,21.26,1.0,2.0,6.0,2.0,,9.8
Montelukast,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,6.0,3.0,6.09,2.51,586.183,8.49,-7.8,70.42,2.0,4.0,12.0,5.0,4.4,3.12
Allopurinol,OC1=NC=NC2=C1C=NN2,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.0,4.29,1.73,136.1115,0.031,-0.79,74.69,2.0,4.0,0.0,2.0,8.47,1.25
Nabilone,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,5.0,10.57,4.48,372.5408,6.36,-5.9,46.53,1.0,3.0,6.0,3.0,9.33,-4.9
Nabilone,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,18.0,9.0,12.32,5.24,372.5408,6.36,-5.9,46.53,1.0,3.0,6.0,3.0,9.33,-4.9
Mazindol,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.0,0.5,1.89,0.76,284.74,3.44,-3.3,35.83,1.0,3.0,1.0,4.0,11.61,3.86
Vitamin A,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,0.8,3.36,1.4,286.4516,4.69,-4.6,20.23,1.0,1.0,5.0,1.0,16.44,-2.2
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.23,0.94,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Fosinopril,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.5,3.27,1.35,563.672,5.62,-5.8,110.21,1.0,5.0,15.0,3.0,3.87,-4.4
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,16.0,5.0,12.32,5.24,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Atomoxetine,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,7.0,15.68,6.71,255.3547,3.81,-4.8,21.26,1.0,2.0,6.0,2.0,,9.8
Ethionamide,CCC1=NC=CC(=C1)C(N)=S,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,2.0,6.12,2.51,166.243,1.33,-2.3,38.91,1.0,1.0,2.0,1.0,11.89,5.0
Vitamin E,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,6.0,1.5,5.55,2.23,430.7061,10.51,-7.8,29.46,1.0,2.0,12.0,2.0,10.8,-4.9
Mazindol,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,5.0,2.5,5.7,2.36,284.74,3.44,-3.3,35.83,1.0,3.0,1.0,4.0,11.61,3.86
Reboxetine,[H][C@@]1(CNCCO1)[C@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,5.0,12.02,5.11,313.397,3.28,-4.2,39.72,1.0,4.0,6.0,3.0,,7.91
Ornithine,NCCC[C@H](N)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,1.0,3.0,1.25,132.161,-3.7,0.11,89.34,3.0,4.0,4.0,0.0,2.67,10.29
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,1.0,3.07,1.29,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Benzatropine,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,5.68,2.36,307.4293,4.19,-5.4,12.47,0.0,2.0,4.0,4.0,,9.54
Cyproheptadine,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.5,3.2,1.31,287.3981,4.38,-4.3,3.24,0.0,1.0,0.0,4.0,,8.05
Baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.0,3.43,1.4,213.661,-0.78,-2.5,63.32,2.0,3.0,4.0,1.0,3.89,9.79
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,5.0,2.0,5.79,2.43,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,12.0,6.0,12.48,5.31,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,7.0,2.5,6.14,2.58,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,0.8,2.18,0.91,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
Leucine,CC(C)C[C@H](N)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.0,0.5,1.84,0.76,131.1729,-1.6,-0.27,63.32,2.0,3.0,3.0,0.0,2.79,9.52
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,5.0,2.5,6.31,2.66,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Lutein,C\C(\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.5,2.16,0.9,568.886,8.55,-5.9,40.46,2.0,2.0,10.0,2.0,18.22,-0.91
Oxytetracycline,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,9.0,3.0,7.11,3.0,460.434,-4.5,-2.5,201.85,7.0,10.0,2.0,4.0,2.84,7.41
Methyclothiazide,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,2.0,4.64,1.92,360.237,0.53,-2.6,109.57,2.0,5.0,2.0,2.0,9.29,-3.4
Fenoprofen,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.5,5.08,2.12,242.2699,3.65,-3.5,46.53,1.0,2.0,4.0,2.0,3.96,-3.7
Indecainide,CC(C)NCCCC1(C(N)=O)C2=CC=CC=C2C2=CC=CC=C12,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.8,1.87,0.77,308.4174,3.26,-5.5,55.12,2.0,2.0,6.0,3.0,16.51,10.4
Fluticasone propionate,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,7.0,3.0,6.09,2.56,500.571,3.72,-4.6,80.67,1.0,4.0,6.0,4.0,13.61,-3.4
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,1.0,2.68,1.07,321.158,3.53,-4.3,61.69,2.0,3.0,1.0,3.0,10.61,-2.2
Pyrazinamide,NC(=O)C1=NC=CN=C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.0,3.5,9.07,3.84,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.5,5.86,2.45,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
Bendroflumethiazide,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,9.0,3.5,12.44,5.29,421.415,1.7,-3.3,118.36,3.0,5.0,4.0,3.0,9.04,-3.1
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,5.0,2.0,6.94,2.91,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,3.0,1.0,5.2,2.13,321.158,3.53,-4.3,61.69,2.0,3.0,1.0,3.0,10.61,-2.2
Lysine,NCCCC[C@H](N)C(O)=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,6.0,2.0,8.54,3.61,146.1876,-3.2,-0.14,89.34,3.0,4.0,5.0,0.0,2.74,10.29
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.5,5.11,2.13,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.0,5.36,2.25,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Atomoxetine,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,3.0,1.5,4.87,2.01,255.3547,3.81,-4.8,21.26,1.0,2.0,6.0,2.0,,9.8
Carbidopa,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,7.0,2.5,5.22,2.19,226.2292,-1.2,-1.8,115.81,5.0,6.0,4.0,1.0,2.35,5.66
Fenoprofen,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,0.8,2.84,1.17,242.2699,3.65,-3.5,46.53,1.0,2.0,4.0,2.0,3.96,-3.7
Leucine,CC(C)C[C@H](N)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,2.0,1.0,3.19,1.31,131.1729,-1.6,-0.27,63.32,2.0,3.0,3.0,0.0,2.79,9.52
Ornithine,NCCC[C@H](N)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.67,1.53,132.161,-3.7,0.11,89.34,3.0,4.0,4.0,0.0,2.67,10.29
Gadoteridol,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,6.0,2.0,5.82,2.45,558.68,-6.8,-1.8,153.58,1.0,11.0,8.0,1.0,1.46,8.3
Tranexamic acid,NC[C@H]1CC[C@@H](CC1)C(O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,5.0,2.0,6.75,2.83,157.2102,-1.6,-0.94,63.32,2.0,3.0,2.0,1.0,4.56,10.22
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,7.0,3.0,8.56,3.61,162.2316,1.16,-0.24,16.13,0.0,2.0,1.0,2.0,,8.58
Trospium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.5,3.77,1.48,392.518,-0.5,-6.8,46.53,1.0,2.0,5.0,5.0,11.05,-4.5
Dihydroergotamine,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,10.0,4.5,8.58,3.63,583.6774,2.71,-3.4,118.21,3.0,6.0,4.0,8.0,9.71,8.39
Acarbose,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.5,5.44,2.29,645.608,-8.3,-0.78,329.01,14.0,19.0,13.0,3.0,11.83,7.03
Biotin,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,3.3,1.35,244.311,0.32,-2.3,78.43,3.0,3.0,5.0,2.0,4.4,-1.9
Timolol,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.04,0.83,316.42,1.34,-3.1,79.74,2.0,7.0,7.0,2.0,14.08,9.76
Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,15.0,8.0,12.39,5.28,780.9385,2.37,-3.8,203.06,6.0,13.0,7.0,8.0,7.15,-3.0
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.5,3.38,1.39,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Disopyramide,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,18.0,7.0,13.23,5.64,339.4745,3.47,-3.8,59.22,1.0,3.0,8.0,2.0,16.19,10.42
Timolol,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,2.0,3.22,1.31,316.42,1.34,-3.1,79.74,2.0,7.0,7.0,2.0,14.08,9.76
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.0,3.14,1.27,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,3.0,5.48,2.28,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,3.19,1.29,307.282,2.12,-4.6,111.43,1.0,5.0,5.0,2.0,10.62,-4.2
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.5,2.67,1.08,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Chloroquine,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,3.0,1.0,4.75,1.92,319.872,3.93,-4.3,28.16,1.0,3.0,8.0,2.0,,10.32
Lysine,NCCCC[C@H](N)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,2.0,6.9,2.91,146.1876,-3.2,-0.14,89.34,3.0,4.0,5.0,0.0,2.74,10.29
Fenoprofen,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,17.0,8.0,12.21,5.2,242.2699,3.65,-3.5,46.53,1.0,2.0,4.0,2.0,3.96,-3.7
Lutein,C\C(\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,8.0,3.0,12.22,5.2,568.886,8.55,-5.9,40.46,2.0,2.0,10.0,2.0,18.22,-0.91
Codeine,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,2.5,7.16,3.02,299.3642,1.34,-2.7,41.93,1.0,4.0,1.0,5.0,13.78,9.19
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,1.5,4.8,2.01,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,3.0,1.25,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,7.0,3.5,6.61,2.77,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,2.5,7.7,3.25,780.9385,2.37,-3.8,203.06,6.0,13.0,7.0,8.0,7.15,-3.0
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,9.0,4.5,11.66,4.96,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Oxaliplatin,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,10.0,3.5,9.96,4.18,397.294,-0.47,-1.2,85.82,0.0,0.0,0.0,3.0,,
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,6.0,3.0,4.96,2.06,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Nitric Oxide,[N]=O,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,5.0,16.75,7.16,30.0061,-0.35,,34.14,0.0,1.0,0.0,0.0,,-2.9
Timolol,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,3.0,7.26,3.05,316.42,1.34,-3.1,79.74,2.0,7.0,7.0,2.0,14.08,9.76
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,9.0,4.0,6.97,2.93,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Cystine,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,4.0,1.0,7.61,3.2,240.3,-5.9,-1.2,126.64,4.0,6.0,7.0,0.0,1.56,9.34
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.0,4.61,1.92,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Nimodipine,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.5,5.39,2.27,418.4403,2.54,-4.5,117.0,1.0,6.0,10.0,2.0,16.96,-4.1
Pyrazinamide,NC(=O)C1=NC=CN=C1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.5,0.5,1.96,0.81,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.5,3.29,1.36,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.5,3.26,1.34,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
Metolazone,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.5,2.7,5.13,2.13,365.835,2.94,-4.0,92.5,2.0,4.0,2.0,3.0,9.54,-1.6
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,6.19,2.61,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Oxytetracycline,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,7.0,2.5,6.25,2.63,460.434,-4.5,-2.5,201.85,7.0,10.0,2.0,4.0,2.84,7.41
Sucralfate,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,8.0,3.0,7.15,3.02,1558.67,-5.9,-3.3,772.17,16.0,35.0,37.0,2.0,13.53,-3.0
Sulfadiazine,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,10.0,4.0,8.31,3.5,250.277,0.39,-2.6,97.97,2.0,5.0,2.0,2.0,6.99,2.01
Cyproheptadine,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,3.5,5.39,2.24,287.3981,4.38,-4.3,3.24,0.0,1.0,0.0,4.0,,8.05
Cefdinir,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,4.0,1.0,5.6,2.33,395.414,-0.89,-3.6,158.21,4.0,8.0,5.0,3.0,2.73,3.61
Adenosine phosphate,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,3.0,1.0,4.82,2.02,347.2212,-4.7,,186.07,5.0,10.0,4.0,3.0,1.23,3.92
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,3.5,6.67,2.79,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,3.0,7.48,3.15,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Cefdinir,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.14,0.88,395.414,-0.89,-3.6,158.21,4.0,8.0,5.0,3.0,2.73,3.61
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,1.0,4.72,1.97,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Amodiaquine,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,6.5,2.3,5.86,2.4,355.861,3.8,-4.6,48.39,2.0,4.0,6.0,3.0,9.1,10.17
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,0.5,2.44,0.94,297.415,4.2,-5.0,21.26,1.0,2.0,6.0,3.0,,9.7
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.0,3.61,1.51,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
Calcifediol,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,4.0,2.0,4.63,1.9,400.6371,5.65,-5.3,40.46,2.0,2.0,6.0,3.0,18.38,-0.98
Ethionamide,CCC1=NC=CC(=C1)C(N)=S,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,4.0,1.0,4.85,1.97,166.243,1.33,-2.3,38.91,1.0,1.0,2.0,1.0,11.89,5.0
Pentagastrin,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,4.0,7.83,3.31,767.9,1.05,-5.5,250.91,8.0,8.0,22.0,3.0,4.0,
Fluorouracil,FC1=CNC(=O)NC1=O,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,7.5,15.15,6.48,130.0772,-0.66,-1.4,58.2,2.0,2.0,0.0,1.0,7.18,-8.0
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,15.0,7.0,12.07,5.13,341.426,0.22,-2.8,101.73,2.0,5.0,6.0,2.0,10.24,8.39
Asparagine,N[C@@H](CC(N)=O)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.75,1.57,132.1179,-4.3,0.1,106.41,3.0,4.0,3.0,0.0,2.0,8.43
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.0,4.36,1.79,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,1.0,0.5,2.29,0.96,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Disopyramide,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,3.5,7.18,3.01,339.4745,3.47,-3.8,59.22,1.0,3.0,8.0,2.0,16.19,10.42
Methyclothiazide,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,2.0,6.69,2.8,360.237,0.53,-2.6,109.57,2.0,5.0,2.0,2.0,9.29,-3.4
Cefdinir,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,9.0,4.0,9.04,3.82,395.414,-0.89,-3.6,158.21,4.0,8.0,5.0,3.0,2.73,3.61
Pentagastrin,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,17.0,8.0,12.54,5.34,767.9,1.05,-5.5,250.91,8.0,8.0,22.0,3.0,4.0,
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.08,0.86,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,2.5,5.86,2.47,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,3.5,7.43,3.13,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
Nabilone,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,2.0,2.96,1.18,372.5408,6.36,-5.9,46.53,1.0,3.0,6.0,3.0,9.33,-4.9
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,5.0,2.0,5.64,2.36,341.426,0.22,-2.8,101.73,2.0,5.0,6.0,2.0,10.24,8.39
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,17.0,7.0,14.16,6.04,318.864,4.54,-4.9,6.48,0.0,2.0,4.0,3.0,,9.2
Baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,3.0,5.07,2.1,213.661,-0.78,-2.5,63.32,2.0,3.0,4.0,1.0,3.89,9.79
Pentagastrin,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,8.0,4.0,7.33,3.09,767.9,1.05,-5.5,250.91,8.0,8.0,22.0,3.0,4.0,
Fosinopril,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,3.5,7.45,3.13,563.672,5.62,-5.8,110.21,1.0,5.0,15.0,3.0,3.87,-4.4
Acetyldigitoxin,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,3.0,5.21,2.18,806.9757,4.04,-4.8,188.9,4.0,12.0,9.0,8.0,7.18,0.24
Mephenytoin,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.0,5.26,2.2,218.2518,1.67,-2.4,49.41,1.0,2.0,2.0,2.0,11.09,-8.1
Esmolol,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,16.0,8.0,13.96,5.96,295.374,1.82,-3.3,67.79,2.0,4.0,10.0,1.0,14.09,9.67
Trospium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,5.0,9.09,3.81,392.518,-0.5,-6.8,46.53,1.0,2.0,5.0,5.0,11.05,-4.5
Ethambutol,CC[C@@H](CO)NCCN[C@@H](CC)CO,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.0,4.0,8.94,3.78,204.3098,-0.059,,64.52,4.0,4.0,9.0,0.0,14.82,9.55
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,4.0,1.5,5.71,2.4,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,3.05,1.27,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Metolazone,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,5.92,2.47,365.835,2.94,-4.0,92.5,2.0,4.0,2.0,3.0,9.54,-1.6
Vitamin E,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,3.0,1.0,4.96,1.98,430.7061,10.51,-7.8,29.46,1.0,2.0,12.0,2.0,10.8,-4.9
Dihydroergotamine,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,17.0,8.5,12.43,5.29,583.6774,2.71,-3.4,118.21,3.0,6.0,4.0,8.0,9.71,8.39
Vitamin A,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,1.5,6.01,2.53,286.4516,4.69,-4.6,20.23,1.0,1.0,5.0,1.0,16.44,-2.2
Bendroflumethiazide,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,5.0,16.36,7.0,421.415,1.7,-3.3,118.36,3.0,5.0,4.0,3.0,9.04,-3.1
Sucralfate,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,4.0,1.5,3.08,1.28,1558.67,-5.9,-3.3,772.17,16.0,35.0,37.0,2.0,13.53,-3.0
Loratadine,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.09,0.85,382.883,4.55,-4.5,42.43,0.0,2.0,2.0,4.0,,4.33
Beclomethasone dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,13.0,6.5,12.14,5.17,521.042,4.43,-5.4,106.97,1.0,5.0,8.0,4.0,13.85,-3.3
Cefdinir,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,8.0,3.0,4.69,1.95,395.414,-0.89,-3.6,158.21,4.0,8.0,5.0,3.0,2.73,3.61
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,3.38,1.4,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Oseltamivir,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,1.0,2.97,1.24,312.4045,1.16,-2.7,90.65,2.0,4.0,8.0,1.0,14.03,9.31
Montelukast,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,6.0,14.83,6.33,586.183,8.49,-7.8,70.42,2.0,4.0,12.0,5.0,4.4,3.12
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,7.0,15.49,6.62,162.2316,1.16,-0.24,16.13,0.0,2.0,1.0,2.0,,8.58
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,3.0,7.7,3.25,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,4.0,2.0,7.98,3.37,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Nitisinone,[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,10.0,4.0,7.86,3.32,329.2281,3.13,-4.6,94.35,0.0,5.0,4.0,2.0,7.44,-7.3
Vitamin E,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,2.0,0.7,3.87,1.5,430.7061,10.51,-7.8,29.46,1.0,2.0,12.0,2.0,10.8,-4.9
Lysine,NCCCC[C@H](N)C(O)=O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,3.0,5.66,2.37,146.1876,-3.2,-0.14,89.34,3.0,4.0,5.0,0.0,2.74,10.29
Cefdinir,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.0,5.19,2.16,395.414,-0.89,-3.6,158.21,4.0,8.0,5.0,3.0,2.73,3.61
Lymecycline,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)=C(O)[C@H]2N(C)C,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,4.0,1.5,2.21,0.92,602.6328,-7.1,-2.7,242.98,9.0,13.0,10.0,4.0,2.51,9.77
Oxiconazole,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,3.0,1.0,4.42,1.77,429.12,5.84,-5.4,39.41,0.0,3.0,6.0,3.0,,6.74
Ramipril,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,1.5,4.73,1.98,416.5106,1.47,-4.0,95.94,2.0,5.0,10.0,3.0,3.75,5.2
Ceftazidime,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,4.0,11.86,5.04,546.576,-4.2,-5.0,191.22,3.0,10.0,9.0,4.0,2.42,4.02
Acetyldigitoxin,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,2.0,3.37,1.4,806.9757,4.04,-4.8,188.9,4.0,12.0,9.0,8.0,7.18,0.24
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,6.5,2.8,5.78,2.36,318.864,4.54,-4.9,6.48,0.0,2.0,4.0,3.0,,9.2
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,3.0,1.0,5.44,2.28,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Dihydroergotamine,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,9.0,4.0,6.94,2.93,583.6774,2.71,-3.4,118.21,3.0,6.0,4.0,8.0,9.71,8.39
Montelukast,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,2.0,3.13,1.25,586.183,8.49,-7.8,70.42,2.0,4.0,12.0,5.0,4.4,3.12
Cefdinir,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,8.0,3.0,7.06,2.97,395.414,-0.89,-3.6,158.21,4.0,8.0,5.0,3.0,2.73,3.61
Fondaparinux,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.5,3.07,1.28,1508.263,-10.0,-2.3,805.48,19.0,44.0,27.0,5.0,-3.0,
Baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,3.5,5.48,2.27,213.661,-0.78,-2.5,63.32,2.0,3.0,4.0,1.0,3.89,9.79
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,4.0,1.0,5.29,2.22,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Secobarbital,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,9.0,3.0,9.07,3.84,238.2829,2.03,-2.3,75.27,2.0,3.0,5.0,1.0,7.48,
Ethionamide,CCC1=NC=CC(=C1)C(N)=S,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,5.0,1.5,6.52,2.69,166.243,1.33,-2.3,38.91,1.0,1.0,2.0,1.0,11.89,5.0
Montelukast,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,10.0,5.0,12.48,5.31,586.183,8.49,-7.8,70.42,2.0,4.0,12.0,5.0,4.4,3.12
Atomoxetine,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,5.0,2.5,7.24,3.04,255.3547,3.81,-4.8,21.26,1.0,2.0,6.0,2.0,,9.8
Calcifediol,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,1.0,2.49,1.0,400.6371,5.65,-5.3,40.46,2.0,2.0,6.0,3.0,18.38,-0.98
Fondaparinux,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.5,3.59,1.5,1508.263,-10.0,-2.3,805.48,19.0,44.0,27.0,5.0,-3.0,
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,8.0,3.0,7.86,3.29,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Zanamivir,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,16.0,5.0,14.28,6.09,332.3098,-5.8,-1.7,200.72,7.0,10.0,6.0,1.0,3.06,11.93
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,2.87,1.19,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,3.5,5.45,2.27,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Dihydroergotamine,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,5.0,2.0,3.58,1.49,583.6774,2.71,-3.4,118.21,3.0,6.0,4.0,8.0,9.71,8.39
alpha-Linolenic acid,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,12.0,4.0,13.54,5.78,278.4296,6.06,-6.0,37.3,1.0,2.0,13.0,0.0,4.99,
Sucralfate,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,5.0,16.6,7.1,1558.67,-5.9,-3.3,772.17,16.0,35.0,37.0,2.0,13.53,-3.0
Oxytetracycline,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,18.0,6.0,14.2,6.06,460.434,-4.5,-2.5,201.85,7.0,10.0,2.0,4.0,2.84,7.41
Fluticasone propionate,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,16.0,7.0,13.95,5.95,500.571,3.72,-4.6,80.67,1.0,4.0,6.0,4.0,13.61,-3.4
Ramipril,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,8.0,3.0,12.11,5.15,416.5106,1.47,-4.0,95.94,2.0,5.0,10.0,3.0,3.75,5.2
Gefitinib,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,9.0,3.0,8.12,3.41,446.902,3.75,-4.2,68.74,1.0,7.0,8.0,4.0,16.11,6.85
Disopyramide,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.5,3.14,1.28,339.4745,3.47,-3.8,59.22,1.0,3.0,8.0,2.0,16.19,10.42
Pyrazinamide,NC(=O)C1=NC=CN=C1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,5.5,2.2,5.59,2.34,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Acarbose,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,10.0,4.0,9.5,4.02,645.608,-8.3,-0.78,329.01,14.0,19.0,13.0,3.0,11.83,7.03
Ipratropium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,6.0,2.0,6.25,2.55,332.463,-1.8,-5.5,46.53,1.0,2.0,6.0,3.0,15.15,-2.7
Asparagine,N[C@@H](CC(N)=O)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,2.5,0.9,5.38,2.26,132.1179,-4.3,0.1,106.41,3.0,4.0,3.0,0.0,2.0,8.43
Cystine,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,4.0,1.0,5.63,2.35,240.3,-5.9,-1.2,126.64,4.0,6.0,7.0,0.0,1.56,9.34
Codeine,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,3.0,5.63,2.36,299.3642,1.34,-2.7,41.93,1.0,4.0,1.0,5.0,13.78,9.19
Vitamin A,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,12.0,3.0,12.06,5.13,286.4516,4.69,-4.6,20.23,1.0,1.0,5.0,1.0,16.44,-2.2
Carbidopa,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,18.0,7.0,14.02,5.98,226.2292,-1.2,-1.8,115.81,5.0,6.0,4.0,1.0,2.35,5.66
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,0.5,2.13,0.88,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Acarbose,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.5,3.05,1.28,645.608,-8.3,-0.78,329.01,14.0,19.0,13.0,3.0,11.83,7.03
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,2.68,1.07,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Fosinopril,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,3.0,5.08,2.12,563.672,5.62,-5.8,110.21,1.0,5.0,15.0,3.0,3.87,-4.4
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.0,0.5,1.9,0.78,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
Methyclothiazide,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,1.0,2.13,0.87,360.237,0.53,-2.6,109.57,2.0,5.0,2.0,2.0,9.29,-3.4
Sucralfate,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.3,0.96,1558.67,-5.9,-3.3,772.17,16.0,35.0,37.0,2.0,13.53,-3.0
Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,10.0,4.0,13.44,5.73,226.2722,1.89,-2.4,75.27,2.0,3.0,4.0,1.0,7.48,
Gadoteridol,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,11.0,3.5,8.73,3.69,558.68,-6.8,-1.8,153.58,1.0,11.0,8.0,1.0,1.46,8.3
Montelukast,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.0,4.0,8.09,3.38,586.183,8.49,-7.8,70.42,2.0,4.0,12.0,5.0,4.4,3.12
Vitamin E,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,4.0,1.0,4.63,1.83,430.7061,10.51,-7.8,29.46,1.0,2.0,12.0,2.0,10.8,-4.9
Allopurinol,OC1=NC=NC2=C1C=NN2,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,8.0,3.0,10.5,4.44,136.1115,0.031,-0.79,74.69,2.0,4.0,0.0,2.0,8.47,1.25
Bendroflumethiazide,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,1.5,5.31,2.22,421.415,1.7,-3.3,118.36,3.0,5.0,4.0,3.0,9.04,-3.1
Oseltamivir,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,6.0,3.0,7.34,3.1,312.4045,1.16,-2.7,90.65,2.0,4.0,8.0,1.0,14.03,9.31
Carbidopa,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.5,3.46,1.44,226.2292,-1.2,-1.8,115.81,5.0,6.0,4.0,1.0,2.35,5.66
Pentagastrin,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,2.04,0.86,767.9,1.05,-5.5,250.91,8.0,8.0,22.0,3.0,4.0,
Pyrazinamide,NC(=O)C1=NC=CN=C1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,10.0,4.0,13.76,5.87,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Fosinopril,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,7.0,15.96,6.83,563.672,5.62,-5.8,110.21,1.0,5.0,15.0,3.0,3.87,-4.4
Zanamivir,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,18.0,6.0,16.67,7.13,332.3098,-5.8,-1.7,200.72,7.0,10.0,6.0,1.0,3.06,11.93
Loratadine,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.5,1.93,0.79,382.883,4.55,-4.5,42.43,0.0,2.0,2.0,4.0,,4.33
Ceftazidime,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,5.0,2.0,5.57,2.32,546.576,-4.2,-5.0,191.22,3.0,10.0,9.0,4.0,2.42,4.02
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,2.0,4.36,1.8,162.2316,1.16,-0.24,16.13,0.0,2.0,1.0,2.0,,8.58
Cinnarizine,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,1.0,2.01,0.82,368.524,5.88,,6.48,0.0,2.0,6.0,4.0,,8.1
Allopurinol,OC1=NC=NC2=C1C=NN2,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,1.0,3.93,1.57,136.1115,0.031,-0.79,74.69,2.0,4.0,0.0,2.0,8.47,1.25
Dydrogesterone,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,6.5,2.8,5.21,2.16,312.4458,3.79,-4.8,34.14,0.0,2.0,1.0,4.0,19.4,-4.8
Atomoxetine,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,7.0,3.5,8.07,3.4,255.3547,3.81,-4.8,21.26,1.0,2.0,6.0,2.0,,9.8
Sucralfate,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.5,3.6,1.5,1558.67,-5.9,-3.3,772.17,16.0,35.0,37.0,2.0,13.53,-3.0
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,10.0,5.0,8.86,3.74,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Cystine,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.0,3.39,1.4,240.3,-5.9,-1.2,126.64,4.0,6.0,7.0,0.0,1.56,9.34
Ethambutol,CC[C@@H](CO)NCCN[C@@H](CC)CO,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,8.0,4.0,8.29,3.5,204.3098,-0.059,,64.52,4.0,4.0,9.0,0.0,14.82,9.55
Lutein,C\C(\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,10.0,4.0,12.48,5.31,568.886,8.55,-5.9,40.46,2.0,2.0,10.0,2.0,18.22,-0.91
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,8.0,4.0,8.7,3.68,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Mazindol,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,3.0,1.5,5.33,2.2,284.74,3.44,-3.3,35.83,1.0,3.0,1.0,4.0,11.61,3.86
Amodiaquine,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,2.88,1.13,355.861,3.8,-4.6,48.39,2.0,4.0,6.0,3.0,9.1,10.17
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,10.0,5.0,9.36,3.97,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Fluticasone propionate,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,3.0,7.72,3.26,500.571,3.72,-4.6,80.67,1.0,4.0,6.0,4.0,13.61,-3.4
Timolol,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,1.89,0.77,316.42,1.34,-3.1,79.74,2.0,7.0,7.0,2.0,14.08,9.76
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,9.0,3.0,12.19,5.19,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Atomoxetine,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,1.5,0.7,3.18,1.3,255.3547,3.81,-4.8,21.26,1.0,2.0,6.0,2.0,,9.8
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,1.8,4.87,2.04,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.0,3.5,7.6,3.15,318.864,4.54,-4.9,6.48,0.0,2.0,4.0,3.0,,9.2
Oxyphencyclimine,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,8.0,3.0,6.64,2.79,344.4479,2.62,-3.8,62.13,1.0,4.0,6.0,3.0,11.54,9.27
Gefitinib,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.5,1.91,0.77,446.902,3.75,-4.2,68.74,1.0,7.0,8.0,4.0,16.11,6.85
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.0,4.86,2.0,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,1.0,2.1,0.85,213.661,-0.78,-2.5,63.32,2.0,3.0,4.0,1.0,3.89,9.79
Nabilone,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,5.0,2.5,2.41,0.95,372.5408,6.36,-5.9,46.53,1.0,3.0,6.0,3.0,9.33,-4.9
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.28,0.95,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Thiethylperazine,CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,0.7,2.48,0.96,399.616,4.66,-4.9,9.72,0.0,3.0,6.0,4.0,,8.0
Chloroquine,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,6.0,3.0,6.02,2.47,319.872,3.93,-4.3,28.16,1.0,3.0,8.0,2.0,,10.32
Reboxetine,[H][C@@]1(CNCCO1)[C@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,1.95,0.81,313.397,3.28,-4.2,39.72,1.0,4.0,6.0,3.0,,7.91
Cystine,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,4.0,1.0,5.22,2.18,240.3,-5.9,-1.2,126.64,4.0,6.0,7.0,0.0,1.56,9.34
Oseltamivir,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,2.0,1.0,3.49,1.46,312.4045,1.16,-2.7,90.65,2.0,4.0,8.0,1.0,14.03,9.31
Carmustine,ClCCNC(=O)N(CCCl)N=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.0,5.18,2.15,214.05,1.02,-2.2,61.77,1.0,2.0,5.0,0.0,13.36,-5.3
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,9.0,3.5,12.65,5.38,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,2.96,1.16,297.415,4.2,-5.0,21.26,1.0,2.0,6.0,3.0,,9.7
Ramipril,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,2.0,0.5,3.4,1.41,416.5106,1.47,-4.0,95.94,2.0,5.0,10.0,3.0,3.75,5.2
Gefitinib,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,18.0,6.0,15.7,6.71,446.902,3.75,-4.2,68.74,1.0,7.0,8.0,4.0,16.11,6.85
Allopurinol,OC1=NC=NC2=C1C=NN2,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,5.0,2.0,6.4,2.64,136.1115,0.031,-0.79,74.69,2.0,4.0,0.0,2.0,8.47,1.25
Zanamivir,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,2.0,7.48,3.16,332.3098,-5.8,-1.7,200.72,7.0,10.0,6.0,1.0,3.06,11.93
Mephenytoin,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,2.5,7.72,3.26,218.2518,1.67,-2.4,49.41,1.0,2.0,2.0,2.0,11.09,-8.1
Zanamivir,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.0,3.74,1.57,332.3098,-5.8,-1.7,200.72,7.0,10.0,6.0,1.0,3.06,11.93
Carmustine,ClCCNC(=O)N(CCCl)N=O,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,18.0,6.0,16.02,6.85,214.05,1.02,-2.2,61.77,1.0,2.0,5.0,0.0,13.36,-5.3
Oseltamivir,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,16.0,8.0,12.3,5.24,312.4045,1.16,-2.7,90.65,2.0,4.0,8.0,1.0,14.03,9.31
Calcifediol,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,12.0,6.0,12.72,5.42,400.6371,5.65,-5.3,40.46,2.0,2.0,6.0,3.0,18.38,-0.98
Bivalirudin,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,13.0,6.5,9.4,3.98,2180.2853,-14.0,-4.7,901.57,28.0,37.0,66.0,6.0,2.78,11.88
Vitamin E,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,4.0,1.5,8.33,3.47,430.7061,10.51,-7.8,29.46,1.0,2.0,12.0,2.0,10.8,-4.9
Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,7.0,2.5,7.93,3.32,307.282,2.12,-4.6,111.43,1.0,5.0,5.0,2.0,10.62,-4.2
Cinnarizine,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,1.5,4.97,2.06,368.524,5.88,,6.48,0.0,2.0,6.0,4.0,,8.1
Dydrogesterone,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,1.5,4.31,1.78,312.4458,3.79,-4.8,34.14,0.0,2.0,1.0,4.0,19.4,-4.8
Dihydroergotamine,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.5,2.92,1.21,583.6774,2.71,-3.4,118.21,3.0,6.0,4.0,8.0,9.71,8.39
Loratadine,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.0,5.88,2.45,382.883,4.55,-4.5,42.43,0.0,2.0,2.0,4.0,,4.33
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,5.83,2.43,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.0,4.5,1.87,226.2722,1.89,-2.4,75.27,2.0,3.0,4.0,1.0,7.48,
Loratadine,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,2.5,5.5,2.29,382.883,4.55,-4.5,42.43,0.0,2.0,2.0,4.0,,4.33
Gefitinib,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,4.0,1.2,2.77,1.12,446.902,3.75,-4.2,68.74,1.0,7.0,8.0,4.0,16.11,6.85
Esmolol,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.5,2.2,4.76,1.99,295.374,1.82,-3.3,67.79,2.0,4.0,10.0,1.0,14.09,9.67
Gadoteridol,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,12.0,4.5,12.33,5.25,558.68,-6.8,-1.8,153.58,1.0,11.0,8.0,1.0,1.46,8.3
Calcifediol,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,2.0,4.14,1.69,400.6371,5.65,-5.3,40.46,2.0,2.0,6.0,3.0,18.38,-0.98
Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,5.0,2.0,8.81,3.72,226.2722,1.89,-2.4,75.27,2.0,3.0,4.0,1.0,7.48,
Fluorouracil,FC1=CNC(=O)NC1=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.5,0.75,1.82,0.72,130.0772,-0.66,-1.4,58.2,2.0,2.0,0.0,1.0,7.18,-8.0
Fluorouracil,FC1=CNC(=O)NC1=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,4.0,2.0,4.76,1.95,130.0772,-0.66,-1.4,58.2,2.0,2.0,0.0,1.0,7.18,-8.0
Oxaliplatin,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.5,0.8,2.43,0.92,397.294,-0.47,-1.2,85.82,0.0,0.0,0.0,3.0,,
Dexrazoxane,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,0.5,2.26,0.95,268.2691,-2.7,-1.4,98.82,2.0,6.0,3.0,2.0,11.2,3.2
Nabilone,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,8.0,4.0,6.14,2.54,372.5408,6.36,-5.9,46.53,1.0,3.0,6.0,3.0,9.33,-4.9
Carbidopa,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,8.0,3.0,7.28,3.07,226.2292,-1.2,-1.8,115.81,5.0,6.0,4.0,1.0,2.35,5.66
Methyclothiazide,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,5.92,2.47,360.237,0.53,-2.6,109.57,2.0,5.0,2.0,2.0,9.29,-3.4
Nitric Oxide,[N]=O,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,4.0,12.56,5.34,30.0061,-0.35,,34.14,0.0,1.0,0.0,0.0,,-2.9
Ethionamide,CCC1=NC=CC(=C1)C(N)=S,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,7.0,2.0,7.77,3.24,166.243,1.33,-2.3,38.91,1.0,1.0,2.0,1.0,11.89,5.0
Fenoprofen,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.0,0.5,1.95,0.81,242.2699,3.65,-3.5,46.53,1.0,2.0,4.0,2.0,3.96,-3.7
Benzatropine,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,3.5,7.18,3.01,307.4293,4.19,-5.4,12.47,0.0,2.0,4.0,4.0,,9.54
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.0,5.89,2.46,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Thiethylperazine,CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,12.0,4.5,10.33,4.36,399.616,4.66,-4.9,9.72,0.0,3.0,6.0,4.0,,8.0
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,8.0,4.0,6.41,2.68,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Lysine,NCCCC[C@H](N)C(O)=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,11.0,4.0,12.38,5.27,146.1876,-3.2,-0.14,89.34,3.0,4.0,5.0,0.0,2.74,10.29
Levocarnitine,C[N+](C)(C)C[C@H](O)CC([O-])=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,3.0,1.0,4.02,1.6,161.1989,-4.9,-1.6,60.36,1.0,3.0,4.0,0.0,4.2,-3.6
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,1.98,0.83,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Nitric Oxide,[N]=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,7.0,3.5,2.38,1.0,30.0061,-0.35,,34.14,0.0,1.0,0.0,0.0,,-2.9
Acetyldigitoxin,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,13.0,6.5,12.07,5.14,806.9757,4.04,-4.8,188.9,4.0,12.0,9.0,8.0,7.18,0.24
Dydrogesterone,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,6.5,2.8,4.72,1.95,312.4458,3.79,-4.8,34.14,0.0,2.0,1.0,4.0,19.4,-4.8
Lysine,NCCCC[C@H](N)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,3.0,1.0,5.15,2.16,146.1876,-3.2,-0.14,89.34,3.0,4.0,5.0,0.0,2.74,10.29
L-Glutamine,N[C@@H](CCC(N)=O)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,6.0,3.0,5.37,2.26,146.1445,-4.0,-0.17,106.41,3.0,4.0,4.0,0.0,2.15,9.31
Asparagine,N[C@@H](CC(N)=O)C(O)=O,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,5.0,2.0,14.29,6.09,132.1179,-4.3,0.1,106.41,3.0,4.0,3.0,0.0,2.0,8.43
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,18.0,7.0,12.45,5.3,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.2,3.46,1.44,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
L-Glutamine,N[C@@H](CCC(N)=O)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,7.0,3.5,7.17,3.03,146.1445,-4.0,-0.17,106.41,3.0,4.0,4.0,0.0,2.15,9.31
Tranexamic acid,NC[C@H]1CC[C@@H](CC1)C(O)=O,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,10.0,4.0,13.32,5.68,157.2102,-1.6,-0.94,63.32,2.0,3.0,2.0,1.0,4.56,10.22
Betamethasone,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.0,5.23,2.19,392.4611,1.68,-3.9,94.83,3.0,5.0,2.0,4.0,12.42,-3.3
Nitric Oxide,[N]=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,16.0,8.0,5.04,2.12,30.0061,-0.35,,34.14,0.0,1.0,0.0,0.0,,-2.9
L-Glutamine,N[C@@H](CCC(N)=O)C(O)=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,6.31,2.66,146.1445,-4.0,-0.17,106.41,3.0,4.0,4.0,0.0,2.15,9.31
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,7.0,15.94,6.82,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
Indecainide,CC(C)NCCCC1(C(N)=O)C2=CC=CC=C2C2=CC=CC=C12,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,8.0,3.0,6.86,2.88,308.4174,3.26,-5.5,55.12,2.0,2.0,6.0,3.0,16.51,10.4
Ethionamide,CCC1=NC=CC(=C1)C(N)=S,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,8.0,2.0,10.62,4.48,166.243,1.33,-2.3,38.91,1.0,1.0,2.0,1.0,11.89,5.0
Codeine,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,4.0,1.2,2.87,1.19,299.3642,1.34,-2.7,41.93,1.0,4.0,1.0,5.0,13.78,9.19
Oxaliplatin,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,4.0,1.0,4.62,1.84,397.294,-0.47,-1.2,85.82,0.0,0.0,0.0,3.0,,
Chloroquine,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,7.0,3.0,7.08,2.94,319.872,3.93,-4.3,28.16,1.0,3.0,8.0,2.0,,10.32
Trospium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,1.0,1.6,0.6,392.518,-0.5,-6.8,46.53,1.0,2.0,5.0,5.0,11.05,-4.5
Loratadine,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,8.0,3.0,6.66,2.79,382.883,4.55,-4.5,42.43,0.0,2.0,2.0,4.0,,4.33
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,10.0,4.0,12.99,5.53,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Dydrogesterone,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.5,4.81,1.99,312.4458,3.79,-4.8,34.14,0.0,2.0,1.0,4.0,19.4,-4.8
Nitric Oxide,[N]=O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,4.0,1.5,5.99,2.52,30.0061,-0.35,,34.14,0.0,1.0,0.0,0.0,,-2.9
Trospium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,7.0,3.5,5.02,2.02,392.518,-0.5,-6.8,46.53,1.0,2.0,5.0,5.0,11.05,-4.5
Fenoprofen,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.49,1.44,242.2699,3.65,-3.5,46.53,1.0,2.0,4.0,2.0,3.96,-3.7
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,6.0,3.0,9.53,4.03,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Fondaparinux,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,17.0,8.0,12.69,5.4,1508.263,-10.0,-2.3,805.48,19.0,44.0,27.0,5.0,-3.0,
Nitric Oxide,[N]=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,5.0,2.0,6.4,2.7,30.0061,-0.35,,34.14,0.0,1.0,0.0,0.0,,-2.9
Montelukast,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,2.0,3.01,1.2,586.183,8.49,-7.8,70.42,2.0,4.0,12.0,5.0,4.4,3.12
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,4.0,2.0,2.75,1.13,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Carbidopa,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,9.0,3.5,6.98,2.94,226.2292,-1.2,-1.8,115.81,5.0,6.0,4.0,1.0,2.35,5.66
Cinnarizine,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.0,5.75,2.39,368.524,5.88,,6.48,0.0,2.0,6.0,4.0,,8.1
Indecainide,CC(C)NCCCC1(C(N)=O)C2=CC=CC=C2C2=CC=CC=C12,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,5.8,2.42,308.4174,3.26,-5.5,55.12,2.0,2.0,6.0,3.0,16.51,10.4
Methyclothiazide,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.5,5.04,2.09,360.237,0.53,-2.6,109.57,2.0,5.0,2.0,2.0,9.29,-3.4
Lymecycline,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)=C(O)[C@H]2N(C)C,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,13.0,5.0,12.3,5.23,602.6328,-7.1,-2.7,242.98,9.0,13.0,10.0,4.0,2.51,9.77
Amodiaquine,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,16.0,6.0,12.07,5.12,355.861,3.8,-4.6,48.39,2.0,4.0,6.0,3.0,9.1,10.17
Ceftazidime,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,6.0,16.03,6.85,546.576,-4.2,-5.0,191.22,3.0,10.0,9.0,4.0,2.42,4.02
Levocarnitine,C[N+](C)(C)C[C@H](O)CC([O-])=O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.5,3.95,1.57,161.1989,-4.9,-1.6,60.36,1.0,3.0,4.0,0.0,4.2,-3.6
Betamethasone,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,6.0,2.5,6.89,2.9,392.4611,1.68,-3.9,94.83,3.0,5.0,2.0,4.0,12.42,-3.3
Acarbose,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.5,3.57,1.5,645.608,-8.3,-0.78,329.01,14.0,19.0,13.0,3.0,11.83,7.03
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,4.0,2.0,6.37,2.66,162.2316,1.16,-0.24,16.13,0.0,2.0,1.0,2.0,,8.58
Sulfadiazine,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,0.5,2.11,0.86,250.277,0.39,-2.6,97.97,2.0,5.0,2.0,2.0,6.99,2.01
Oxyphencyclimine,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,2.76,1.13,344.4479,2.62,-3.8,62.13,1.0,4.0,6.0,3.0,11.54,9.27
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,6.0,3.0,4.81,1.99,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Leucine,CC(C)C[C@H](N)C(O)=O,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,10.0,4.0,15.78,6.75,131.1729,-1.6,-0.27,63.32,2.0,3.0,3.0,0.0,2.79,9.52
Fluorouracil,FC1=CNC(=O)NC1=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,6.0,3.0,6.47,2.69,130.0772,-0.66,-1.4,58.2,2.0,2.0,0.0,1.0,7.18,-8.0
Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.34,1.37,226.2722,1.89,-2.4,75.27,2.0,3.0,4.0,1.0,7.48,
Fosinopril,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.5,5.87,2.45,563.672,5.62,-5.8,110.21,1.0,5.0,15.0,3.0,3.87,-4.4
Sucralfate,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,7.0,2.5,6.3,2.65,1558.67,-5.9,-3.3,772.17,16.0,35.0,37.0,2.0,13.53,-3.0
Disopyramide,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.28,1.34,339.4745,3.47,-3.8,59.22,1.0,3.0,8.0,2.0,16.19,10.42
alpha-Linolenic acid,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,10.0,5.0,8.88,3.75,278.4296,6.06,-6.0,37.3,1.0,2.0,13.0,0.0,4.99,
Carmustine,ClCCNC(=O)N(CCCl)N=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.0,4.68,1.94,214.05,1.02,-2.2,61.77,1.0,2.0,5.0,0.0,13.36,-5.3
Beclomethasone dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,2.0,3.32,1.37,521.042,4.43,-5.4,106.97,1.0,5.0,8.0,4.0,13.85,-3.3
Acarbose,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,3.5,7.96,3.36,645.608,-8.3,-0.78,329.01,14.0,19.0,13.0,3.0,11.83,7.03
Fenoprofen,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,5.0,2.0,3.35,1.38,242.2699,3.65,-3.5,46.53,1.0,2.0,4.0,2.0,3.96,-3.7
Acarbose,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,18.0,7.0,12.71,5.41,645.608,-8.3,-0.78,329.01,14.0,19.0,13.0,3.0,11.83,7.03
Gadoteridol,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,0.8,2.25,0.94,558.68,-6.8,-1.8,153.58,1.0,11.0,8.0,1.0,1.46,8.3
Bendroflumethiazide,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,0.5,2.19,0.91,421.415,1.7,-3.3,118.36,3.0,5.0,4.0,3.0,9.04,-3.1
Loratadine,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.5,3.29,1.35,382.883,4.55,-4.5,42.43,0.0,2.0,2.0,4.0,,4.33
Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.8,1.97,0.82,780.9385,2.37,-3.8,203.06,6.0,13.0,7.0,8.0,7.15,-3.0
Dihydroergotamine,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,1.0,2.16,0.9,583.6774,2.71,-3.4,118.21,3.0,6.0,4.0,8.0,9.71,8.39
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.0,0.5,2.05,0.86,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Chloroquine,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,1.7,0.66,319.872,3.93,-4.3,28.16,1.0,3.0,8.0,2.0,,10.32
Benzatropine,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,2.0,4.82,1.99,307.4293,4.19,-5.4,12.47,0.0,2.0,4.0,4.0,,9.54
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,7.0,3.0,6.13,2.57,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.5,0.8,2.93,1.22,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Levocarnitine,C[N+](C)(C)C[C@H](O)CC([O-])=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,3.0,1.0,4.69,1.88,161.1989,-4.9,-1.6,60.36,1.0,3.0,4.0,0.0,4.2,-3.6
Nitisinone,[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,8.0,3.0,5.8,2.44,329.2281,3.13,-4.6,94.35,0.0,5.0,4.0,2.0,7.44,-7.3
Beclomethasone dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.5,2.1,0.87,521.042,4.43,-5.4,106.97,1.0,5.0,8.0,4.0,13.85,-3.3
Bendroflumethiazide,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,4.0,12.18,5.18,421.415,1.7,-3.3,118.36,3.0,5.0,4.0,3.0,9.04,-3.1
Gefitinib,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,2.5,6.8,2.84,446.902,3.75,-4.2,68.74,1.0,7.0,8.0,4.0,16.11,6.85
Pyrazinamide,NC(=O)C1=NC=CN=C1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,7.5,3.2,8.43,3.56,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Nitisinone,[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,15.0,5.5,12.58,5.35,329.2281,3.13,-4.6,94.35,0.0,5.0,4.0,2.0,7.44,-7.3
Beclomethasone dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,9.0,4.5,7.52,3.17,521.042,4.43,-5.4,106.97,1.0,5.0,8.0,4.0,13.85,-3.3
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,12.0,5.0,8.61,3.64,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Timolol,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,3.0,4.99,2.07,316.42,1.34,-3.1,79.74,2.0,7.0,7.0,2.0,14.08,9.76
Loratadine,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,2.81,1.15,382.883,4.55,-4.5,42.43,0.0,2.0,2.0,4.0,,4.33
Bendroflumethiazide,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,9.0,3.5,8.6,3.64,421.415,1.7,-3.3,118.36,3.0,5.0,4.0,3.0,9.04,-3.1
Carbidopa,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,13.0,5.0,12.48,5.31,226.2292,-1.2,-1.8,115.81,5.0,6.0,4.0,1.0,2.35,5.66
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,8.0,3.0,8.6,3.64,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Asparagine,N[C@@H](CC(N)=O)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,1.5,0.6,3.6,1.51,132.1179,-4.3,0.1,106.41,3.0,4.0,3.0,0.0,2.0,8.43
Levocarnitine,C[N+](C)(C)C[C@H](O)CC([O-])=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,2.0,5.36,2.17,161.1989,-4.9,-1.6,60.36,1.0,3.0,4.0,0.0,4.2,-3.6
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,16.0,5.0,12.24,5.21,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
Dydrogesterone,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,16.0,6.0,13.08,5.58,312.4458,3.79,-4.8,34.14,0.0,2.0,1.0,4.0,19.4,-4.8
Vitamin A,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,16.0,5.0,13.86,5.91,286.4516,4.69,-4.6,20.23,1.0,1.0,5.0,1.0,16.44,-2.2
Trospium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.5,2.5,0.95,392.518,-0.5,-6.8,46.53,1.0,2.0,5.0,5.0,11.05,-4.5
Fluticasone propionate,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,8.0,3.0,8.57,3.62,500.571,3.72,-4.6,80.67,1.0,4.0,6.0,4.0,13.61,-3.4
Secobarbital,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,11.0,3.8,12.23,5.21,238.2829,2.03,-2.3,75.27,2.0,3.0,5.0,1.0,7.48,
Calcifediol,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,10.0,5.0,11.19,4.76,400.6371,5.65,-5.3,40.46,2.0,2.0,6.0,3.0,18.38,-0.98
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.5,5.31,2.22,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,2.0,1.0,4.92,2.02,307.282,2.12,-4.6,111.43,1.0,5.0,5.0,2.0,10.62,-4.2
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.0,0.5,2.12,0.89,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Acetyldigitoxin,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.5,4.71,1.97,806.9757,4.04,-4.8,188.9,4.0,12.0,9.0,8.0,7.18,0.24
Acetyldigitoxin,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.5,2.86,1.19,806.9757,4.04,-4.8,188.9,4.0,12.0,9.0,8.0,7.18,0.24
Baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,0.8,2.81,1.14,213.661,-0.78,-2.5,63.32,2.0,3.0,4.0,1.0,3.89,9.79
Sucralfate,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,6.0,2.0,4.94,2.08,1558.67,-5.9,-3.3,772.17,16.0,35.0,37.0,2.0,13.53,-3.0
Methyclothiazide,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,6.0,2.0,6.96,2.92,360.237,0.53,-2.6,109.57,2.0,5.0,2.0,2.0,9.29,-3.4
Fluticasone propionate,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.0,3.43,1.43,500.571,3.72,-4.6,80.67,1.0,4.0,6.0,4.0,13.61,-3.4
Oxaliplatin,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,1.5,3.87,1.52,397.294,-0.47,-1.2,85.82,0.0,0.0,0.0,3.0,,
Nimodipine,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,18.0,9.0,16.55,7.08,418.4403,2.54,-4.5,117.0,1.0,6.0,10.0,2.0,16.96,-4.1
Atomoxetine,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,4.0,2.0,4.96,2.05,255.3547,3.81,-4.8,21.26,1.0,2.0,6.0,2.0,,9.8
Ethambutol,CC[C@@H](CO)NCCN[C@@H](CC)CO,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,4.0,2.0,5.48,2.29,204.3098,-0.059,,64.52,4.0,4.0,9.0,0.0,14.82,9.55
Acarbose,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,2.0,3.72,1.56,645.608,-8.3,-0.78,329.01,14.0,19.0,13.0,3.0,11.83,7.03
Adenosine phosphate,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,1.8,5.33,2.23,347.2212,-4.7,,186.07,5.0,10.0,4.0,3.0,1.23,3.92
Secobarbital,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,1.5,4.66,1.94,238.2829,2.03,-2.3,75.27,2.0,3.0,5.0,1.0,7.48,
Montelukast,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,1.0,1.94,0.76,586.183,8.49,-7.8,70.42,2.0,4.0,12.0,5.0,4.4,3.12
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,2.0,4.75,1.98,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,2.0,3.56,1.48,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Ornithine,NCCC[C@H](N)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.0,5.29,2.22,132.161,-3.7,0.11,89.34,3.0,4.0,4.0,0.0,2.67,10.29
Fluticasone propionate,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.5,2.0,0.83,500.571,3.72,-4.6,80.67,1.0,4.0,6.0,4.0,13.61,-3.4
Betamethasone,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.8,3.39,1.41,392.4611,1.68,-3.9,94.83,3.0,5.0,2.0,4.0,12.42,-3.3
Pentagastrin,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,2.0,3.65,1.52,767.9,1.05,-5.5,250.91,8.0,8.0,22.0,3.0,4.0,
Cefdinir,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.0,5.98,2.5,395.414,-0.89,-3.6,158.21,4.0,8.0,5.0,3.0,2.73,3.61
Ornithine,NCCC[C@H](N)C(O)=O,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,16.0,7.0,14.16,6.04,132.161,-3.7,0.11,89.34,3.0,4.0,4.0,0.0,2.67,10.29
Fenoprofen,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,6.0,2.5,5.58,2.33,242.2699,3.65,-3.5,46.53,1.0,2.0,4.0,2.0,3.96,-3.7
Ramipril,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,2.0,6.89,2.9,416.5106,1.47,-4.0,95.94,2.0,5.0,10.0,3.0,3.75,5.2
Sucralfate,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,10.0,3.0,12.68,5.39,1558.67,-5.9,-3.3,772.17,16.0,35.0,37.0,2.0,13.53,-3.0
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.0,5.23,2.19,341.426,0.22,-2.8,101.73,2.0,5.0,6.0,2.0,10.24,8.39
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,20.0,10.0,16.24,6.95,341.426,0.22,-2.8,101.73,2.0,5.0,6.0,2.0,10.24,8.39
Pyrazinamide,NC(=O)C1=NC=CN=C1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.5,1.45,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Tranexamic acid,NC[C@H]1CC[C@@H](CC1)C(O)=O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,5.0,2.0,5.33,2.22,157.2102,-1.6,-0.94,63.32,2.0,3.0,2.0,1.0,4.56,10.22
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,6.0,3.0,6.93,2.88,321.158,3.53,-4.3,61.69,2.0,3.0,1.0,3.0,10.61,-2.2
Carbidopa,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,9.0,3.5,9.29,3.93,226.2292,-1.2,-1.8,115.81,5.0,6.0,4.0,1.0,2.35,5.66
Ethionamide,CCC1=NC=CC(=C1)C(N)=S,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,4.0,14.42,6.15,166.243,1.33,-2.3,38.91,1.0,1.0,2.0,1.0,11.89,5.0
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,1.0,0.5,2.98,1.25,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Cyproheptadine,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,3.0,1.0,4.9,2.03,287.3981,4.38,-4.3,3.24,0.0,1.0,0.0,4.0,,8.05
Amodiaquine,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.0,4.45,1.79,355.861,3.8,-4.6,48.39,2.0,4.0,6.0,3.0,9.1,10.17
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,5.0,1.8,5.81,2.45,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Lymecycline,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)=C(O)[C@H]2N(C)C,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,7.0,2.5,4.83,2.03,602.6328,-7.1,-2.7,242.98,9.0,13.0,10.0,4.0,2.51,9.77
Mazindol,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,3.0,1.5,4.44,1.82,284.74,3.44,-3.3,35.83,1.0,3.0,1.0,4.0,11.61,3.86
Disopyramide,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.2,4.82,1.99,339.4745,3.47,-3.8,59.22,1.0,3.0,8.0,2.0,16.19,10.42
Fluorouracil,FC1=CNC(=O)NC1=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,2.5,6.23,2.58,130.0772,-0.66,-1.4,58.2,2.0,2.0,0.0,1.0,7.18,-8.0
Betamethasone,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.0,3.5,9.18,3.88,392.4611,1.68,-3.9,94.83,3.0,5.0,2.0,4.0,12.42,-3.3
Gefitinib,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.0,2.5,8.76,3.69,446.902,3.75,-4.2,68.74,1.0,7.0,8.0,4.0,16.11,6.85
Fenoprofen,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,16.0,7.0,11.96,5.08,242.2699,3.65,-3.5,46.53,1.0,2.0,4.0,2.0,3.96,-3.7
Timolol,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,9.0,4.0,8.1,3.41,316.42,1.34,-3.1,79.74,2.0,7.0,7.0,2.0,14.08,9.76
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,10.0,3.5,9.26,3.92,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Ramipril,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.0,5.24,2.19,416.5106,1.47,-4.0,95.94,2.0,5.0,10.0,3.0,3.75,5.2
Pyrazinamide,NC(=O)C1=NC=CN=C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,5.0,16.14,6.9,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Carmustine,ClCCNC(=O)N(CCCl)N=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.8,1.98,0.81,214.05,1.02,-2.2,61.77,1.0,2.0,5.0,0.0,13.36,-5.3
Timolol,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,2.0,3.35,1.37,316.42,1.34,-3.1,79.74,2.0,7.0,7.0,2.0,14.08,9.76
Timolol,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,7.0,15.69,6.71,316.42,1.34,-3.1,79.74,2.0,7.0,7.0,2.0,14.08,9.76
Acetyldigitoxin,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,8.0,4.0,5.63,2.36,806.9757,4.04,-4.8,188.9,4.0,12.0,9.0,8.0,7.18,0.24
Cystine,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,2.0,6.83,2.87,240.3,-5.9,-1.2,126.64,4.0,6.0,7.0,0.0,1.56,9.34
Benzatropine,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.5,4.91,2.03,307.4293,4.19,-5.4,12.47,0.0,2.0,4.0,4.0,,9.54
Dihydroergotamine,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,3.0,1.5,4.77,2.0,583.6774,2.71,-3.4,118.21,3.0,6.0,4.0,8.0,9.71,8.39
Ornithine,NCCC[C@H](N)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,1.0,0.5,2.23,0.93,132.161,-3.7,0.11,89.34,3.0,4.0,4.0,0.0,2.67,10.29
Ethionamide,CCC1=NC=CC(=C1)C(N)=S,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,1.5,4.48,1.81,166.243,1.33,-2.3,38.91,1.0,1.0,2.0,1.0,11.89,5.0
Oxytetracycline,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,20.0,7.0,16.58,7.09,460.434,-4.5,-2.5,201.85,7.0,10.0,2.0,4.0,2.84,7.41
Esmolol,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,1.99,0.83,295.374,1.82,-3.3,67.79,2.0,4.0,10.0,1.0,14.09,9.67
Lysine,NCCCC[C@H](N)C(O)=O,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,4.0,12.12,5.16,146.1876,-3.2,-0.14,89.34,3.0,4.0,5.0,0.0,2.74,10.29
Nabilone,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,3.0,4.46,1.81,372.5408,6.36,-5.9,46.53,1.0,3.0,6.0,3.0,9.33,-4.9
Leucine,CC(C)C[C@H](N)C(O)=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,5.0,2.0,5.76,2.4,131.1729,-1.6,-0.27,63.32,2.0,3.0,3.0,0.0,2.79,9.52
L-Glutamine,N[C@@H](CCC(N)=O)C(O)=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,10.0,4.0,12.72,5.42,146.1445,-4.0,-0.17,106.41,3.0,4.0,4.0,0.0,2.15,9.31
Ethambutol,CC[C@@H](CO)NCCN[C@@H](CC)CO,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,5.87,2.45,204.3098,-0.059,,64.52,4.0,4.0,9.0,0.0,14.82,9.55
Fenoprofen,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,4.0,1.5,2.11,0.87,242.2699,3.65,-3.5,46.53,1.0,2.0,4.0,2.0,3.96,-3.7
Ipratropium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,1.0,1.6,0.6,332.463,-1.8,-5.5,46.53,1.0,2.0,6.0,3.0,15.15,-2.7
Cystine,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,6.0,2.0,7.12,2.99,240.3,-5.9,-1.2,126.64,4.0,6.0,7.0,0.0,1.56,9.34
Acarbose,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,6.0,2.5,5.35,2.25,645.608,-8.3,-0.78,329.01,14.0,19.0,13.0,3.0,11.83,7.03
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.5,3.72,1.56,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Mazindol,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,1.0,0.5,2.05,0.82,284.74,3.44,-3.3,35.83,1.0,3.0,1.0,4.0,11.61,3.86
Bivalirudin,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,12.0,6.0,12.61,5.37,2180.2853,-14.0,-4.7,901.57,28.0,37.0,66.0,6.0,2.78,11.88
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.0,4.77,1.96,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Ceftazidime,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.48,1.43,546.576,-4.2,-5.0,191.22,3.0,10.0,9.0,4.0,2.42,4.02
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,2.0,1.0,3.65,1.53,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Acetyldigitoxin,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,16.0,8.0,13.87,5.92,806.9757,4.04,-4.8,188.9,4.0,12.0,9.0,8.0,7.18,0.24
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.0,0.8,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Ethionamide,CCC1=NC=CC(=C1)C(N)=S,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,1.8,5.2,2.12,166.243,1.33,-2.3,38.91,1.0,1.0,2.0,1.0,11.89,5.0
Metolazone,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,5.0,11.78,5.01,365.835,2.94,-4.0,92.5,2.0,4.0,2.0,3.0,9.54,-1.6
Biotin,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.0,5.89,2.46,244.311,0.32,-2.3,78.43,3.0,3.0,5.0,2.0,4.4,-1.9
Ceftazidime,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.0,0.3,1.96,0.81,546.576,-4.2,-5.0,191.22,3.0,10.0,9.0,4.0,2.42,4.02
Beclomethasone dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.5,2.82,1.16,521.042,4.43,-5.4,106.97,1.0,5.0,8.0,4.0,13.85,-3.3
Leucine,CC(C)C[C@H](N)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.5,4.89,2.03,131.1729,-1.6,-0.27,63.32,2.0,3.0,3.0,0.0,2.79,9.52
Beclomethasone dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,6.0,3.0,4.64,1.93,521.042,4.43,-5.4,106.97,1.0,5.0,8.0,4.0,13.85,-3.3
Ramipril,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,3.0,7.18,3.03,416.5106,1.47,-4.0,95.94,2.0,5.0,10.0,3.0,3.75,5.2
Trospium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,2.0,3.37,1.31,392.518,-0.5,-6.8,46.53,1.0,2.0,5.0,5.0,11.05,-4.5
Dydrogesterone,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,1.0,1.92,0.78,312.4458,3.79,-4.8,34.14,0.0,2.0,1.0,4.0,19.4,-4.8
Benzatropine,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,9.0,4.5,8.65,3.65,307.4293,4.19,-5.4,12.47,0.0,2.0,4.0,4.0,,9.54
Amodiaquine,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,2.5,6.48,2.67,355.861,3.8,-4.6,48.39,2.0,4.0,6.0,3.0,9.1,10.17
Ramipril,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,7.0,3.0,12.36,5.26,416.5106,1.47,-4.0,95.94,2.0,5.0,10.0,3.0,3.75,5.2
Reboxetine,[H][C@@]1(CNCCO1)[C@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.5,2.85,1.18,313.397,3.28,-4.2,39.72,1.0,4.0,6.0,3.0,,7.91
alpha-Linolenic acid,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,4.0,7.4,3.12,278.4296,6.06,-6.0,37.3,1.0,2.0,13.0,0.0,4.99,
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,18.0,6.0,12.5,5.32,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
Ornithine,NCCC[C@H](N)C(O)=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,8.0,3.0,8.73,3.69,132.161,-3.7,0.11,89.34,3.0,4.0,4.0,0.0,2.67,10.29
Lysine,NCCCC[C@H](N)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,0.5,2.14,0.89,146.1876,-3.2,-0.14,89.34,3.0,4.0,5.0,0.0,2.74,10.29
Esmolol,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,7.5,3.8,6.09,2.56,295.374,1.82,-3.3,67.79,2.0,4.0,10.0,1.0,14.09,9.67
Lutein,C\C(\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,3.5,7.27,3.07,568.886,8.55,-5.9,40.46,2.0,2.0,10.0,2.0,18.22,-0.91
Gadoteridol,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,3.02,1.26,558.68,-6.8,-1.8,153.58,1.0,11.0,8.0,1.0,1.46,8.3
Pyrazinamide,NC(=O)C1=NC=CN=C1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,0.7,2.12,0.88,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,7.0,2.5,7.04,2.91,297.415,4.2,-5.0,21.26,1.0,2.0,6.0,3.0,,9.7
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,1.92,0.79,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,2.5,7.75,3.27,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Oxaliplatin,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,6.0,2.0,6.18,2.51,397.294,-0.47,-1.2,85.82,0.0,0.0,0.0,3.0,,
Indecainide,CC(C)NCCCC1(C(N)=O)C2=CC=CC=C2C2=CC=CC=C12,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,9.0,3.5,6.57,2.75,308.4174,3.26,-5.5,55.12,2.0,2.0,6.0,3.0,16.51,10.4
Cystine,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,10.0,4.0,13.77,5.87,240.3,-5.9,-1.2,126.64,4.0,6.0,7.0,0.0,1.56,9.34
Sulfadiazine,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,7.0,2.5,5.04,2.09,250.277,0.39,-2.6,97.97,2.0,5.0,2.0,2.0,6.99,2.01
Beclomethasone dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,7.0,3.5,6.74,2.83,521.042,4.43,-5.4,106.97,1.0,5.0,8.0,4.0,13.85,-3.3
Ipratropium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,8.0,3.0,10.7,4.52,332.463,-1.8,-5.5,46.53,1.0,2.0,6.0,3.0,15.15,-2.7
Levocarnitine,C[N+](C)(C)C[C@H](O)CC([O-])=O,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,8.0,3.0,9.63,4.05,161.1989,-4.9,-1.6,60.36,1.0,3.0,4.0,0.0,4.2,-3.6
Oxaliplatin,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,4.0,1.0,4.28,1.69,397.294,-0.47,-1.2,85.82,0.0,0.0,0.0,3.0,,
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.0,4.0,9.19,3.89,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,1.5,5.31,2.23,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,7.0,3.0,5.22,2.18,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Chloroquine,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,7.0,14.31,6.11,319.872,3.93,-4.3,28.16,1.0,3.0,8.0,2.0,,10.32
Pyrazinamide,NC(=O)C1=NC=CN=C1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,9.0,3.8,12.22,5.2,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Thiethylperazine,CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,2.0,5.85,2.39,399.616,4.66,-4.9,9.72,0.0,3.0,6.0,4.0,,8.0
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.5,0.5,2.0,0.84,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.0,6.27,2.64,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Sulfadiazine,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.0,4.63,1.92,250.277,0.39,-2.6,97.97,2.0,5.0,2.0,2.0,6.99,2.01
Vitamin A,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,9.0,2.5,9.14,3.87,286.4516,4.69,-4.6,20.23,1.0,1.0,5.0,1.0,16.44,-2.2
Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,1.0,0.5,2.01,0.82,226.2722,1.89,-2.4,75.27,2.0,3.0,4.0,1.0,7.48,
Montelukast,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,2.57,1.01,586.183,8.49,-7.8,70.42,2.0,4.0,12.0,5.0,4.4,3.12
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,3.0,10.18,4.29,297.415,4.2,-5.0,21.26,1.0,2.0,6.0,3.0,,9.7
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,12.0,6.0,13.19,5.62,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,5.0,15.36,6.56,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Oxytetracycline,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,16.0,5.0,12.39,5.27,460.434,-4.5,-2.5,201.85,7.0,10.0,2.0,4.0,2.84,7.41
Codeine,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,2.0,4.71,1.97,299.3642,1.34,-2.7,41.93,1.0,4.0,1.0,5.0,13.78,9.19
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.5,4.9,2.02,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.0,5.62,2.32,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Oxiconazole,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,5.0,2.0,6.41,2.63,429.12,5.84,-5.4,39.41,0.0,3.0,6.0,3.0,,6.74
Baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,2.0,4.58,1.89,213.661,-0.78,-2.5,63.32,2.0,3.0,4.0,1.0,3.89,9.79
Trospium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,7.0,3.5,6.7,2.75,392.518,-0.5,-6.8,46.53,1.0,2.0,5.0,5.0,11.05,-4.5
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.5,3.2,6.4,2.63,318.864,4.54,-4.9,6.48,0.0,2.0,4.0,3.0,,9.2
Cystine,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.15,0.89,240.3,-5.9,-1.2,126.64,4.0,6.0,7.0,0.0,1.56,9.34
Tranexamic acid,NC[C@H]1CC[C@@H](CC1)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,6.0,2.0,6.47,2.71,157.2102,-1.6,-0.94,63.32,2.0,3.0,2.0,1.0,4.56,10.22
Methyclothiazide,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,3.0,5.54,2.3,360.237,0.53,-2.6,109.57,2.0,5.0,2.0,2.0,9.29,-3.4
Acarbose,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,3.0,7.46,3.15,645.608,-8.3,-0.78,329.01,14.0,19.0,13.0,3.0,11.83,7.03
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,7.0,3.0,6.04,2.53,341.426,0.22,-2.8,101.73,2.0,5.0,6.0,2.0,10.24,8.39
Montelukast,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,5.0,10.73,4.54,586.183,8.49,-7.8,70.42,2.0,4.0,12.0,5.0,4.4,3.12
Oxytetracycline,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.0,5.41,2.27,460.434,-4.5,-2.5,201.85,7.0,10.0,2.0,4.0,2.84,7.41
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,2.0,1.0,3.5,1.46,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Gefitinib,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.38,1.38,446.902,3.75,-4.2,68.74,1.0,7.0,8.0,4.0,16.11,6.85
Esmolol,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,5.5,2.8,5.17,2.17,295.374,1.82,-3.3,67.79,2.0,4.0,10.0,1.0,14.09,9.67
Nitric Oxide,[N]=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,9.0,3.5,12.82,5.46,30.0061,-0.35,,34.14,0.0,1.0,0.0,0.0,,-2.9
Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,18.0,12.0,12.14,5.16,780.9385,2.37,-3.8,203.06,6.0,13.0,7.0,8.0,7.15,-3.0
Baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,17.0,8.0,11.64,4.94,213.661,-0.78,-2.5,63.32,2.0,3.0,4.0,1.0,3.89,9.79
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.0,4.57,1.9,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
L-Glutamine,N[C@@H](CCC(N)=O)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,1.0,2.29,0.96,146.1445,-4.0,-0.17,106.41,3.0,4.0,4.0,0.0,2.15,9.31
Adenosine phosphate,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,5.0,1.8,6.16,2.59,347.2212,-4.7,,186.07,5.0,10.0,4.0,3.0,1.23,3.92
Dexrazoxane,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,1.5,4.9,2.06,268.2691,-2.7,-1.4,98.82,2.0,6.0,3.0,2.0,11.2,3.2
Loratadine,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,2.0,6.94,2.91,382.883,4.55,-4.5,42.43,0.0,2.0,2.0,4.0,,4.33
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,8.0,3.0,5.74,2.41,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
Oxaliplatin,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.5,0.5,1.78,0.66,397.294,-0.47,-1.2,85.82,0.0,0.0,0.0,3.0,,
Benzatropine,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,17.0,8.5,15.6,6.67,307.4293,4.19,-5.4,12.47,0.0,2.0,4.0,4.0,,9.54
Oxytetracycline,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,13.0,4.5,9.44,4.0,460.434,-4.5,-2.5,201.85,7.0,10.0,2.0,4.0,2.84,7.41
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.0,2.5,7.58,3.15,297.415,4.2,-5.0,21.26,1.0,2.0,6.0,3.0,,9.7
Leucine,CC(C)C[C@H](N)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,2.0,1.0,3.32,1.36,131.1729,-1.6,-0.27,63.32,2.0,3.0,3.0,0.0,2.79,9.52
Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.0,5.0,2.08,226.2722,1.89,-2.4,75.27,2.0,3.0,4.0,1.0,7.48,
alpha-Linolenic acid,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,7.0,2.5,8.24,3.48,278.4296,6.06,-6.0,37.3,1.0,2.0,13.0,0.0,4.99,
Loratadine,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,20.0,7.0,15.9,6.8,382.883,4.55,-4.5,42.43,0.0,2.0,2.0,4.0,,4.33
Allopurinol,OC1=NC=NC2=C1C=NN2,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,6.0,2.0,7.66,3.19,136.1115,0.031,-0.79,74.69,2.0,4.0,0.0,2.0,8.47,1.25
Sucralfate,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,6.0,2.0,5.89,2.48,1558.67,-5.9,-3.3,772.17,16.0,35.0,37.0,2.0,13.53,-3.0
Gadoteridol,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,2.5,7.37,3.11,558.68,-6.8,-1.8,153.58,1.0,11.0,8.0,1.0,1.46,8.3
Amodiaquine,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,5.0,1.7,4.37,1.76,355.861,3.8,-4.6,48.39,2.0,4.0,6.0,3.0,9.1,10.17
Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,3.2,1.31,226.2722,1.89,-2.4,75.27,2.0,3.0,4.0,1.0,7.48,
Carmustine,ClCCNC(=O)N(CCCl)N=O,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,17.0,6.0,13.65,5.82,214.05,1.02,-2.2,61.77,1.0,2.0,5.0,0.0,13.36,-5.3
Cyproheptadine,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,4.0,1.5,4.99,2.07,287.3981,4.38,-4.3,3.24,0.0,1.0,0.0,4.0,,8.05
Mephenytoin,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,8.0,2.8,6.92,2.92,218.2518,1.67,-2.4,49.41,1.0,2.0,2.0,2.0,11.09,-8.1
Codeine,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.53,1.47,299.3642,1.34,-2.7,41.93,1.0,4.0,1.0,5.0,13.78,9.19
Bivalirudin,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.5,2.23,0.94,2180.2853,-14.0,-4.7,901.57,28.0,37.0,66.0,6.0,2.78,11.88
Cefdinir,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,15.0,6.0,12.16,5.17,395.414,-0.89,-3.6,158.21,4.0,8.0,5.0,3.0,2.73,3.61
Ethionamide,CCC1=NC=CC(=C1)C(N)=S,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,3.0,10.39,4.39,166.243,1.33,-2.3,38.91,1.0,1.0,2.0,1.0,11.89,5.0
Asparagine,N[C@@H](CC(N)=O)C(O)=O,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,16.0,8.0,12.48,5.31,132.1179,-4.3,0.1,106.41,3.0,4.0,3.0,0.0,2.0,8.43
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,7.0,3.0,7.05,2.97,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Acarbose,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,6.0,2.5,5.87,2.47,645.608,-8.3,-0.78,329.01,14.0,19.0,13.0,3.0,11.83,7.03
Methyclothiazide,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,11.0,5.0,12.0,5.1,360.237,0.53,-2.6,109.57,2.0,5.0,2.0,2.0,9.29,-3.4
Fosinopril,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,5.0,2.5,2.77,1.14,563.672,5.62,-5.8,110.21,1.0,5.0,15.0,3.0,3.87,-4.4
Tranexamic acid,NC[C@H]1CC[C@@H](CC1)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.0,0.5,1.82,0.74,157.2102,-1.6,-0.94,63.32,2.0,3.0,2.0,1.0,4.56,10.22
Adenosine phosphate,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,7.0,2.5,9.3,3.94,347.2212,-4.7,,186.07,5.0,10.0,4.0,3.0,1.23,3.92
Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.0,3.0,9.2,3.9,780.9385,2.37,-3.8,203.06,6.0,13.0,7.0,8.0,7.15,-3.0
Ramipril,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.55,1.47,416.5106,1.47,-4.0,95.94,2.0,5.0,10.0,3.0,3.75,5.2
Secobarbital,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,9.0,3.0,8.42,3.56,238.2829,2.03,-2.3,75.27,2.0,3.0,5.0,1.0,7.48,
Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,12.0,4.5,13.94,5.94,780.9385,2.37,-3.8,203.06,6.0,13.0,7.0,8.0,7.15,-3.0
Dihydroergotamine,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,4.0,7.74,3.27,583.6774,2.71,-3.4,118.21,3.0,6.0,4.0,8.0,9.71,8.39
Fluticasone propionate,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.0,5.27,2.21,500.571,3.72,-4.6,80.67,1.0,4.0,6.0,4.0,13.61,-3.4
Oxyphencyclimine,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.39,1.4,344.4479,2.62,-3.8,62.13,1.0,4.0,6.0,3.0,11.54,9.27
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,10.0,4.0,8.95,3.79,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Lymecycline,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)=C(O)[C@H]2N(C)C,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,5.0,2.0,3.49,1.46,602.6328,-7.1,-2.7,242.98,9.0,13.0,10.0,4.0,2.51,9.77
Mephenytoin,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.5,5.17,2.16,218.2518,1.67,-2.4,49.41,1.0,2.0,2.0,2.0,11.09,-8.1
Nitisinone,[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,14.0,5.0,12.32,5.24,329.2281,3.13,-4.6,94.35,0.0,5.0,4.0,2.0,7.44,-7.3
Lutein,C\C(\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,8.0,4.0,6.97,2.94,568.886,8.55,-5.9,40.46,2.0,2.0,10.0,2.0,18.22,-0.91
Ethambutol,CC[C@@H](CO)NCCN[C@@H](CC)CO,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,17.0,8.5,12.08,5.14,204.3098,-0.059,,64.52,4.0,4.0,9.0,0.0,14.82,9.55
Reboxetine,[H][C@@]1(CNCCO1)[C@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,9.0,4.0,8.46,3.58,313.397,3.28,-4.2,39.72,1.0,4.0,6.0,3.0,,7.91
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,6.0,3.0,7.2,3.03,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Loratadine,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,14.0,5.0,13.53,5.77,382.883,4.55,-4.5,42.43,0.0,2.0,2.0,4.0,,4.33
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,8.0,3.0,14.19,6.05,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Calcifediol,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,5.0,2.5,4.54,1.86,400.6371,5.65,-5.3,40.46,2.0,2.0,6.0,3.0,18.38,-0.98
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,10.0,4.0,14.0,5.97,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Tranexamic acid,NC[C@H]1CC[C@@H](CC1)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,1.5,4.44,1.84,157.2102,-1.6,-0.94,63.32,2.0,3.0,2.0,1.0,4.56,10.22
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,2.0,1.0,3.11,1.26,162.2316,1.16,-0.24,16.13,0.0,2.0,1.0,2.0,,8.58
L-Glutamine,N[C@@H](CCC(N)=O)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,2.11,0.89,146.1445,-4.0,-0.17,106.41,3.0,4.0,4.0,0.0,2.15,9.31
Ipratropium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,2.41,0.91,332.463,-1.8,-5.5,46.53,1.0,2.0,6.0,3.0,15.15,-2.7
Ethionamide,CCC1=NC=CC(=C1)C(N)=S,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.0,3.04,1.2,166.243,1.33,-2.3,38.91,1.0,1.0,2.0,1.0,11.89,5.0
Lutein,C\C(\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.5,5.29,2.22,568.886,8.55,-5.9,40.46,2.0,2.0,10.0,2.0,18.22,-0.91
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,1.85,0.74,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Dexrazoxane,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,3.0,7.43,3.14,268.2691,-2.7,-1.4,98.82,2.0,6.0,3.0,2.0,11.2,3.2
Carbidopa,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.2,2.94,1.23,226.2292,-1.2,-1.8,115.81,5.0,6.0,4.0,1.0,2.35,5.66
Pyrazinamide,NC(=O)C1=NC=CN=C1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.5,5.98,2.51,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Benzatropine,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,3.5,6.69,2.8,307.4293,4.19,-5.4,12.47,0.0,2.0,4.0,4.0,,9.54
Nitisinone,[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,7.0,2.5,6.21,2.61,329.2281,3.13,-4.6,94.35,0.0,5.0,4.0,2.0,7.44,-7.3
Sucralfate,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,6.0,2.0,5.37,2.25,1558.67,-5.9,-3.3,772.17,16.0,35.0,37.0,2.0,13.53,-3.0
Nitric Oxide,[N]=O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.0,3.0,9.61,4.07,30.0061,-0.35,,34.14,0.0,1.0,0.0,0.0,,-2.9
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,1.0,0.5,2.02,0.8,321.158,3.53,-4.3,61.69,2.0,3.0,1.0,3.0,10.61,-2.2
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,9.0,4.0,6.69,2.81,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Cystine,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,7.0,3.0,8.45,3.57,240.3,-5.9,-1.2,126.64,4.0,6.0,7.0,0.0,1.56,9.34
Pentagastrin,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,1.0,2.21,0.93,767.9,1.05,-5.5,250.91,8.0,8.0,22.0,3.0,4.0,
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,16.0,8.0,13.5,5.76,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Ipratropium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,5.0,12.99,5.53,332.463,-1.8,-5.5,46.53,1.0,2.0,6.0,3.0,15.15,-2.7
Fluorouracil,FC1=CNC(=O)NC1=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.5,3.07,1.23,130.0772,-0.66,-1.4,58.2,2.0,2.0,0.0,1.0,7.18,-8.0
Sulfadiazine,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,5.0,15.96,6.82,250.277,0.39,-2.6,97.97,2.0,5.0,2.0,2.0,6.99,2.01
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,1.5,4.78,2.0,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Acetyldigitoxin,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,7.5,16.25,6.95,806.9757,4.04,-4.8,188.9,4.0,12.0,9.0,8.0,7.18,0.24
Pyrazinamide,NC(=O)C1=NC=CN=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,6.5,2.8,6.8,2.86,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Ethambutol,CC[C@@H](CO)NCCN[C@@H](CC)CO,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,3.5,7.46,3.14,204.3098,-0.059,,64.52,4.0,4.0,9.0,0.0,14.82,9.55
Betamethasone,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,8.0,3.5,8.52,3.6,392.4611,1.68,-3.9,94.83,3.0,5.0,2.0,4.0,12.42,-3.3
Oxiconazole,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,12.0,6.0,10.4,4.38,429.12,5.84,-5.4,39.41,0.0,3.0,6.0,3.0,,6.74
alpha-Linolenic acid,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.5,4.54,1.89,278.4296,6.06,-6.0,37.3,1.0,2.0,13.0,0.0,4.99,
Fosinopril,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,2.0,3.41,1.41,563.672,5.62,-5.8,110.21,1.0,5.0,15.0,3.0,3.87,-4.4
Loratadine,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.0,4.6,1.91,382.883,4.55,-4.5,42.43,0.0,2.0,2.0,4.0,,4.33
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,3.0,6.6,2.74,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Reboxetine,[H][C@@]1(CNCCO1)[C@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,2.0,4.69,1.96,313.397,3.28,-4.2,39.72,1.0,4.0,6.0,3.0,,7.91
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,7.0,3.0,5.01,2.09,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.0,0.5,1.85,0.76,226.2722,1.89,-2.4,75.27,2.0,3.0,4.0,1.0,7.48,
Thiethylperazine,CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,6.0,2.0,6.08,2.5,399.616,4.66,-4.9,9.72,0.0,3.0,6.0,4.0,,8.0
Methyclothiazide,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,7.0,2.5,8.28,3.49,360.237,0.53,-2.6,109.57,2.0,5.0,2.0,2.0,9.29,-3.4
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,3.0,1.0,4.84,2.03,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Codeine,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,8.0,3.5,5.12,2.14,299.3642,1.34,-2.7,41.93,1.0,4.0,1.0,5.0,13.78,9.19
Chloroquine,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,1.0,1.83,0.7,319.872,3.93,-4.3,28.16,1.0,3.0,8.0,2.0,,10.32
Ornithine,NCCC[C@H](N)C(O)=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.0,6.22,2.62,132.161,-3.7,0.11,89.34,3.0,4.0,4.0,0.0,2.67,10.29
Lysine,NCCCC[C@H](N)C(O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,5.0,2.0,7.19,3.03,146.1876,-3.2,-0.14,89.34,3.0,4.0,5.0,0.0,2.74,10.29
Fenoprofen,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,6.0,2.5,7.08,2.98,242.2699,3.65,-3.5,46.53,1.0,2.0,4.0,2.0,3.96,-3.7
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.5,3.52,1.47,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Adenosine phosphate,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,5.0,16.42,7.02,347.2212,-4.7,,186.07,5.0,10.0,4.0,3.0,1.23,3.92
Ipratropium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,4.0,1.0,4.41,1.75,332.463,-1.8,-5.5,46.53,1.0,2.0,6.0,3.0,15.15,-2.7
Ipratropium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,5.0,2.0,2.51,0.95,332.463,-1.8,-5.5,46.53,1.0,2.0,6.0,3.0,15.15,-2.7
Nabilone,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,18.0,9.0,14.67,6.27,372.5408,6.36,-5.9,46.53,1.0,3.0,6.0,3.0,9.33,-4.9
Levocarnitine,C[N+](C)(C)C[C@H](O)CC([O-])=O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,4.0,1.5,4.36,1.74,161.1989,-4.9,-1.6,60.36,1.0,3.0,4.0,0.0,4.2,-3.6
Zafirlukast,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,16.0,8.0,13.72,5.85,575.675,6.4,-5.8,115.73,2.0,6.0,8.0,5.0,4.29,-1.1
Lutein,C\C(\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,7.0,3.5,6.12,2.58,568.886,8.55,-5.9,40.46,2.0,2.0,10.0,2.0,18.22,-0.91
Disopyramide,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,0.8,2.67,1.08,339.4745,3.47,-3.8,59.22,1.0,3.0,8.0,2.0,16.19,10.42
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,2.0,5.27,2.21,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Oxyphencyclimine,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.5,1.88,0.78,344.4479,2.62,-3.8,62.13,1.0,4.0,6.0,3.0,11.54,9.27
Zafirlukast,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,1.95,0.81,575.675,6.4,-5.8,115.73,2.0,6.0,8.0,5.0,4.29,-1.1
Oxytetracycline,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,10.0,3.5,7.91,3.34,460.434,-4.5,-2.5,201.85,7.0,10.0,2.0,4.0,2.84,7.41
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,1.0,2.77,1.14,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
Atomoxetine,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,12.0,6.0,11.77,5.01,255.3547,3.81,-4.8,21.26,1.0,2.0,6.0,2.0,,9.8
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,7.0,2.5,6.99,2.95,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
Chloroquine,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,2.42,0.94,319.872,3.93,-4.3,28.16,1.0,3.0,8.0,2.0,,10.32
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,1.88,0.77,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Beclomethasone dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,1.94,0.8,521.042,4.43,-5.4,106.97,1.0,5.0,8.0,4.0,13.85,-3.3
Oxytetracycline,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,7.0,2.5,5.31,2.23,460.434,-4.5,-2.5,201.85,7.0,10.0,2.0,4.0,2.84,7.41
Zanamivir,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.0,2.5,9.52,4.03,332.3098,-5.8,-1.7,200.72,7.0,10.0,6.0,1.0,3.06,11.93
Acetyldigitoxin,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,11.0,5.5,9.15,3.87,806.9757,4.04,-4.8,188.9,4.0,12.0,9.0,8.0,7.18,0.24
Bendroflumethiazide,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.0,6.13,2.57,421.415,1.7,-3.3,118.36,3.0,5.0,4.0,3.0,9.04,-3.1
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,6.0,1.5,7.65,3.23,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Esmolol,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.5,2.91,1.21,295.374,1.82,-3.3,67.79,2.0,4.0,10.0,1.0,14.09,9.67
Baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,9.0,4.5,7.36,3.09,213.661,-0.78,-2.5,63.32,2.0,3.0,4.0,1.0,3.89,9.79
Ramipril,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,1.0,0.5,2.13,0.89,416.5106,1.47,-4.0,95.94,2.0,5.0,10.0,3.0,3.75,5.2
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.5,3.54,1.47,341.426,0.22,-2.8,101.73,2.0,5.0,6.0,2.0,10.24,8.39
Cinnarizine,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.5,1.86,0.76,368.524,5.88,,6.48,0.0,2.0,6.0,4.0,,8.1
Montelukast,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,10.0,5.0,10.97,4.65,586.183,8.49,-7.8,70.42,2.0,4.0,12.0,5.0,4.4,3.12
Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,7.0,3.0,11.91,5.07,226.2722,1.89,-2.4,75.27,2.0,3.0,4.0,1.0,7.48,
Dydrogesterone,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,7.0,3.0,5.58,2.32,312.4458,3.79,-4.8,34.14,0.0,2.0,1.0,4.0,19.4,-4.8
Ipratropium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,5.0,2.0,5.63,2.28,332.463,-1.8,-5.5,46.53,1.0,2.0,6.0,3.0,15.15,-2.7
Levocarnitine,C[N+](C)(C)C[C@H](O)CC([O-])=O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,7.0,2.5,7.1,2.93,161.1989,-4.9,-1.6,60.36,1.0,3.0,4.0,0.0,4.2,-3.6
Ethambutol,CC[C@@H](CO)NCCN[C@@H](CC)CO,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,2.0,4.99,2.08,204.3098,-0.059,,64.52,4.0,4.0,9.0,0.0,14.82,9.55
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,9.0,3.5,8.74,3.7,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Dexrazoxane,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.0,5.42,2.28,268.2691,-2.7,-1.4,98.82,2.0,6.0,3.0,2.0,11.2,3.2
Ramipril,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.5,5.15,2.15,416.5106,1.47,-4.0,95.94,2.0,5.0,10.0,3.0,3.75,5.2
Oxaliplatin,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,2.92,1.12,397.294,-0.47,-1.2,85.82,0.0,0.0,0.0,3.0,,
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,3.5,7.15,3.0,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Fosinopril,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,3.0,5.49,2.29,563.672,5.62,-5.8,110.21,1.0,5.0,15.0,3.0,3.87,-4.4
Ceftazidime,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,10.0,4.0,9.0,3.8,546.576,-4.2,-5.0,191.22,3.0,10.0,9.0,4.0,2.42,4.02
Zanamivir,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.5,2.11,0.89,332.3098,-5.8,-1.7,200.72,7.0,10.0,6.0,1.0,3.06,11.93
Lutein,C\C(\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,11.0,5.5,9.28,3.93,568.886,8.55,-5.9,40.46,2.0,2.0,10.0,2.0,18.22,-0.91
Bivalirudin,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,7.0,3.5,6.22,2.62,2180.2853,-14.0,-4.7,901.57,28.0,37.0,66.0,6.0,2.78,11.88
Cystine,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.0,3.53,1.46,240.3,-5.9,-1.2,126.64,4.0,6.0,7.0,0.0,1.56,9.34
Oxiconazole,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,6.0,3.0,6.02,2.46,429.12,5.84,-5.4,39.41,0.0,3.0,6.0,3.0,,6.74
Vitamin E,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,2.5,0.9,3.58,1.38,430.7061,10.51,-7.8,29.46,1.0,2.0,12.0,2.0,10.8,-4.9
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,10.0,3.5,12.45,5.3,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,17.0,7.0,13.62,5.81,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Benzatropine,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,8.0,4.0,8.01,3.37,307.4293,4.19,-5.4,12.47,0.0,2.0,4.0,4.0,,9.54
Vitamin E,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,1.5,0.6,2.1,0.78,430.7061,10.51,-7.8,29.46,1.0,2.0,12.0,2.0,10.8,-4.9
Codeine,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,17.0,7.0,13.88,5.92,299.3642,1.34,-2.7,41.93,1.0,4.0,1.0,5.0,13.78,9.19
Dihydroergotamine,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,6.1,2.56,583.6774,2.71,-3.4,118.21,3.0,6.0,4.0,8.0,9.71,8.39
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,7.0,2.5,6.96,2.93,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
alpha-Linolenic acid,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.5,4.95,2.06,278.4296,6.06,-6.0,37.3,1.0,2.0,13.0,0.0,4.99,
Mazindol,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,10.0,5.0,15.48,6.62,284.74,3.44,-3.3,35.83,1.0,3.0,1.0,4.0,11.61,3.86
Oseltamivir,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,20.0,10.0,16.49,7.05,312.4045,1.16,-2.7,90.65,2.0,4.0,8.0,1.0,14.03,9.31
Nitisinone,[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.5,3.67,1.53,329.2281,3.13,-4.6,94.35,0.0,5.0,4.0,2.0,7.44,-7.3
Fosinopril,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,1.0,2.06,0.85,563.672,5.62,-5.8,110.21,1.0,5.0,15.0,3.0,3.87,-4.4
Allopurinol,OC1=NC=NC2=C1C=NN2,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,2.83,1.11,136.1115,0.031,-0.79,74.69,2.0,4.0,0.0,2.0,8.47,1.25
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,10.0,3.0,11.83,5.01,297.415,4.2,-5.0,21.26,1.0,2.0,6.0,3.0,,9.7
Trospium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,8.0,4.0,6.23,2.54,392.518,-0.5,-6.8,46.53,1.0,2.0,5.0,5.0,11.05,-4.5
alpha-Linolenic acid,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.5,2.0,6.62,2.78,278.4296,6.06,-6.0,37.3,1.0,2.0,13.0,0.0,4.99,
Zafirlukast,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,12.0,6.0,11.92,5.07,575.675,6.4,-5.8,115.73,2.0,6.0,8.0,5.0,4.29,-1.1
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,9.0,4.0,12.37,5.27,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Leucine,CC(C)C[C@H](N)C(O)=O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,6.0,2.0,8.78,3.71,131.1729,-1.6,-0.27,63.32,2.0,3.0,3.0,0.0,2.79,9.52
Disopyramide,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.0,0.5,1.83,0.74,339.4745,3.47,-3.8,59.22,1.0,3.0,8.0,2.0,16.19,10.42
Tranexamic acid,NC[C@H]1CC[C@@H](CC1)C(O)=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,7.0,3.0,8.07,3.4,157.2102,-1.6,-0.94,63.32,2.0,3.0,2.0,1.0,4.56,10.22
Zanamivir,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,0.8,3.06,1.28,332.3098,-5.8,-1.7,200.72,7.0,10.0,6.0,1.0,3.06,11.93
Ipratropium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,4.0,9.14,3.83,332.463,-1.8,-5.5,46.53,1.0,2.0,6.0,3.0,15.15,-2.7
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,1.0,0.5,1.97,0.8,162.2316,1.16,-0.24,16.13,0.0,2.0,1.0,2.0,,8.58
Ramipril,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,0.5,2.88,1.2,416.5106,1.47,-4.0,95.94,2.0,5.0,10.0,3.0,3.75,5.2
Ceftazidime,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.5,3.34,1.38,546.576,-4.2,-5.0,191.22,3.0,10.0,9.0,4.0,2.42,4.02
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,4.0,7.84,3.31,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Mazindol,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,4.0,2.0,7.96,3.34,284.74,3.44,-3.3,35.83,1.0,3.0,1.0,4.0,11.61,3.86
Chloroquine,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,5.0,10.28,4.34,319.872,3.93,-4.3,28.16,1.0,3.0,8.0,2.0,,10.32
Biotin,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,6.0,2.0,6.67,2.8,244.311,0.32,-2.3,78.43,3.0,3.0,5.0,2.0,4.4,-1.9
Levocarnitine,C[N+](C)(C)C[C@H](O)CC([O-])=O,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,5.0,13.56,5.78,161.1989,-4.9,-1.6,60.36,1.0,3.0,4.0,0.0,4.2,-3.6
Carmustine,ClCCNC(=O)N(CCCl)N=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.5,3.36,1.38,214.05,1.02,-2.2,61.77,1.0,2.0,5.0,0.0,13.36,-5.3
Fluticasone propionate,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,6.0,2.0,6.93,2.92,500.571,3.72,-4.6,80.67,1.0,4.0,6.0,4.0,13.61,-3.4
Calcifediol,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,6.0,3.0,6.35,2.64,400.6371,5.65,-5.3,40.46,2.0,2.0,6.0,3.0,18.38,-0.98
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,6.0,3.0,6.52,2.7,321.158,3.53,-4.3,61.69,2.0,3.0,1.0,3.0,10.61,-2.2
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,8.0,4.0,6.89,2.89,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Indecainide,CC(C)NCCCC1(C(N)=O)C2=CC=CC=C2C2=CC=CC=C12,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,2.0,4.52,1.87,308.4174,3.26,-5.5,55.12,2.0,2.0,6.0,3.0,16.51,10.4
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,4.0,12.39,5.27,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.0,6.07,2.55,780.9385,2.37,-3.8,203.06,6.0,13.0,7.0,8.0,7.15,-3.0
Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,6.0,2.0,7.2,3.04,780.9385,2.37,-3.8,203.06,6.0,13.0,7.0,8.0,7.15,-3.0
Fondaparinux,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,18.0,7.0,14.23,6.07,1508.263,-10.0,-2.3,805.48,19.0,44.0,27.0,5.0,-3.0,
Codeine,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,1.0,2.12,0.88,299.3642,1.34,-2.7,41.93,1.0,4.0,1.0,5.0,13.78,9.19
Bivalirudin,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,8.0,4.0,7.38,3.11,2180.2853,-14.0,-4.7,901.57,28.0,37.0,66.0,6.0,2.78,11.88
Oxyphencyclimine,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,16.0,5.0,13.57,5.79,344.4479,2.62,-3.8,62.13,1.0,4.0,6.0,3.0,11.54,9.27
Beclomethasone dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.5,5.14,2.14,521.042,4.43,-5.4,106.97,1.0,5.0,8.0,4.0,13.85,-3.3
Esmolol,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.5,1.8,3.42,1.42,295.374,1.82,-3.3,67.79,2.0,4.0,10.0,1.0,14.09,9.67
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,6.0,15.56,6.65,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Bivalirudin,CC[C@H](C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](N)CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,7.0,3.5,5.29,2.22,2180.2853,-14.0,-4.7,901.57,28.0,37.0,66.0,6.0,2.78,11.88
Leucine,CC(C)C[C@H](N)C(O)=O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,4.0,1.5,5.38,2.24,131.1729,-1.6,-0.27,63.32,2.0,3.0,3.0,0.0,2.79,9.52
Oseltamivir,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,7.0,3.0,9.36,3.96,312.4045,1.16,-2.7,90.65,2.0,4.0,8.0,1.0,14.03,9.31
Vitamin A,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.0,3.51,1.46,286.4516,4.69,-4.6,20.23,1.0,1.0,5.0,1.0,16.44,-2.2
Lysine,NCCCC[C@H](N)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.0,0.5,1.97,0.82,146.1876,-3.2,-0.14,89.34,3.0,4.0,5.0,0.0,2.74,10.29
Oseltamivir,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,1.0,0.5,2.21,0.92,312.4045,1.16,-2.7,90.65,2.0,4.0,8.0,1.0,14.03,9.31
Vitamin A,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,2.0,7.64,3.23,286.4516,4.69,-4.6,20.23,1.0,1.0,5.0,1.0,16.44,-2.2
Ipratropium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,3.0,1.0,3.71,1.45,332.463,-1.8,-5.5,46.53,1.0,2.0,6.0,3.0,15.15,-2.7
Dexrazoxane,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,3.55,1.49,268.2691,-2.7,-1.4,98.82,2.0,6.0,3.0,2.0,11.2,3.2
alpha-Linolenic acid,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,6.0,2.0,6.91,2.9,278.4296,6.06,-6.0,37.3,1.0,2.0,13.0,0.0,4.99,
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.5,3.39,1.41,341.426,0.22,-2.8,101.73,2.0,5.0,6.0,2.0,10.24,8.39
Zanamivir,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,12.0,4.0,12.48,5.31,332.3098,-5.8,-1.7,200.72,7.0,10.0,6.0,1.0,3.06,11.93
Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,12.0,6.0,11.29,4.79,307.282,2.12,-4.6,111.43,1.0,5.0,5.0,2.0,10.62,-4.2
Allopurinol,OC1=NC=NC2=C1C=NN2,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.0,4.37,1.76,136.1115,0.031,-0.79,74.69,2.0,4.0,0.0,2.0,8.47,1.25
Gefitinib,COC1=C(OCCCN2CCOCC2)C=C2C(NC3=CC(Cl)=C(F)C=C3)=NC=NC2=C1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.0,5.79,2.41,446.902,3.75,-4.2,68.74,1.0,7.0,8.0,4.0,16.11,6.85
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,16.0,8.0,12.77,5.43,321.158,3.53,-4.3,61.69,2.0,3.0,1.0,3.0,10.61,-2.2
Codeine,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,9.0,4.0,6.87,2.89,299.3642,1.34,-2.7,41.93,1.0,4.0,1.0,5.0,13.78,9.19
Ceftazidime,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,8.0,3.0,8.36,3.52,546.576,-4.2,-5.0,191.22,3.0,10.0,9.0,4.0,2.42,4.02
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,20.0,7.0,15.99,6.84,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Oxyphencyclimine,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,5.0,2.0,5.47,2.28,344.4479,2.62,-3.8,62.13,1.0,4.0,6.0,3.0,11.54,9.27
Mazindol,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,3.0,1.5,6.43,2.68,284.74,3.44,-3.3,35.83,1.0,3.0,1.0,4.0,11.61,3.86
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,2.0,3.24,1.33,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Cinnarizine,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.0,4.88,2.02,368.524,5.88,,6.48,0.0,2.0,6.0,4.0,,8.1
Ethionamide,CCC1=NC=CC(=C1)C(N)=S,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,8.0,2.5,7.19,2.98,166.243,1.33,-2.3,38.91,1.0,1.0,2.0,1.0,11.89,5.0
Oxiconazole,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,7.0,3.0,7.6,3.15,429.12,5.84,-5.4,39.41,0.0,3.0,6.0,3.0,,6.74
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,8.0,3.0,11.47,4.87,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Levocarnitine,C[N+](C)(C)C[C@H](O)CC([O-])=O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,5.0,2.0,5.95,2.43,161.1989,-4.9,-1.6,60.36,1.0,3.0,4.0,0.0,4.2,-3.6
Baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,12.0,6.0,8.84,3.72,213.661,-0.78,-2.5,63.32,2.0,3.0,4.0,1.0,3.89,9.79
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,4.5,14.16,6.04,297.415,4.2,-5.0,21.26,1.0,2.0,6.0,3.0,,9.7
Nimodipine,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.5,3.53,1.48,418.4403,2.54,-4.5,117.0,1.0,6.0,10.0,2.0,16.96,-4.1
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.5,1.98,0.8,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,3.0,1.0,4.72,1.93,321.158,3.53,-4.3,61.69,2.0,3.0,1.0,3.0,10.61,-2.2
Oxyphencyclimine,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.0,5.06,2.11,344.4479,2.62,-3.8,62.13,1.0,4.0,6.0,3.0,11.54,9.27
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.0,4.0,8.62,3.63,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Asparagine,N[C@@H](CC(N)=O)C(O)=O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,12.0,6.0,9.53,4.03,132.1179,-4.3,0.1,106.41,3.0,4.0,3.0,0.0,2.0,8.43
Lymecycline,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)=C(O)[C@H]2N(C)C,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,10.0,4.0,8.69,3.68,602.6328,-7.1,-2.7,242.98,9.0,13.0,10.0,4.0,2.51,9.77
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,1.0,0.5,2.14,0.89,341.426,0.22,-2.8,101.73,2.0,5.0,6.0,2.0,10.24,8.39
Nabilone,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,9.0,4.5,5.9,2.43,372.5408,6.36,-5.9,46.53,1.0,3.0,6.0,3.0,9.33,-4.9
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,6.0,2.0,6.35,2.64,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Trospium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,1.0,2.05,0.77,392.518,-0.5,-6.8,46.53,1.0,2.0,5.0,5.0,11.05,-4.5
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.5,5.34,2.24,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Ethionamide,CCC1=NC=CC(=C1)C(N)=S,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.5,1.76,0.68,166.243,1.33,-2.3,38.91,1.0,1.0,2.0,1.0,11.89,5.0
Baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,12.0,6.0,8.2,3.45,213.661,-0.78,-2.5,63.32,2.0,3.0,4.0,1.0,3.89,9.79
Oxaliplatin,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,10.0,4.0,11.32,4.77,397.294,-0.47,-1.2,85.82,0.0,0.0,0.0,3.0,,
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,2.0,4.8,2.01,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Sucralfate,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,12.0,4.0,12.42,5.28,1558.67,-5.9,-3.3,772.17,16.0,35.0,37.0,2.0,13.53,-3.0
Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,0.8,2.14,0.89,780.9385,2.37,-3.8,203.06,6.0,13.0,7.0,8.0,7.15,-3.0
Metolazone,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,12.0,6.0,12.04,5.12,365.835,2.94,-4.0,92.5,2.0,4.0,2.0,3.0,9.54,-1.6
Secobarbital,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.0,5.16,2.16,238.2829,2.03,-2.3,75.27,2.0,3.0,5.0,1.0,7.48,
Leucine,CC(C)C[C@H](N)C(O)=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,8.0,3.0,11.87,5.05,131.1729,-1.6,-0.27,63.32,2.0,3.0,3.0,0.0,2.79,9.52
Metolazone,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.5,0.7,1.95,0.8,365.835,2.94,-4.0,92.5,2.0,4.0,2.0,3.0,9.54,-1.6
Beclomethasone dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,7.5,16.05,6.87,521.042,4.43,-5.4,106.97,1.0,5.0,8.0,4.0,13.85,-3.3
Allopurinol,OC1=NC=NC2=C1C=NN2,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,6.0,2.0,7.08,2.93,136.1115,0.031,-0.79,74.69,2.0,4.0,0.0,2.0,8.47,1.25
Timolol,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.0,4.0,8.73,3.68,316.42,1.34,-3.1,79.74,2.0,7.0,7.0,2.0,14.08,9.76
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,2.0,4.94,2.08,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Pentagastrin,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,5.0,2.5,5.78,2.43,767.9,1.05,-5.5,250.91,8.0,8.0,22.0,3.0,4.0,
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.5,4.55,1.89,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Biotin,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.0,5.02,2.08,244.311,0.32,-2.3,78.43,3.0,3.0,5.0,2.0,4.4,-1.9
Leucine,CC(C)C[C@H](N)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,1.0,0.5,2.7,1.1,131.1729,-1.6,-0.27,63.32,2.0,3.0,3.0,0.0,2.79,9.52
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.4,1.4,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
alpha-Linolenic acid,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.5,3.23,1.33,278.4296,6.06,-6.0,37.3,1.0,2.0,13.0,0.0,4.99,
Oseltamivir,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,4.0,2.0,5.35,2.24,312.4045,1.16,-2.7,90.65,2.0,4.0,8.0,1.0,14.03,9.31
Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,3.0,1.0,5.4,2.25,226.2722,1.89,-2.4,75.27,2.0,3.0,4.0,1.0,7.48,
Allopurinol,OC1=NC=NC2=C1C=NN2,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,10.0,4.0,11.96,5.08,136.1115,0.031,-0.79,74.69,2.0,4.0,0.0,2.0,8.47,1.25
Thiethylperazine,CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,2.0,0.7,2.9,1.13,399.616,4.66,-4.9,9.72,0.0,3.0,6.0,4.0,,8.0
Ornithine,NCCC[C@H](N)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,1.0,4.86,2.04,132.161,-3.7,0.11,89.34,3.0,4.0,4.0,0.0,2.67,10.29
Amodiaquine,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.0,5.17,2.1,355.861,3.8,-4.6,48.39,2.0,4.0,6.0,3.0,9.1,10.17
Asparagine,N[C@@H](CC(N)=O)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,3.0,1.0,7.19,3.03,132.1179,-4.3,0.1,106.41,3.0,4.0,3.0,0.0,2.0,8.43
Nitisinone,[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.2,3.0,1.25,329.2281,3.13,-4.6,94.35,0.0,5.0,4.0,2.0,7.44,-7.3
Nitric Oxide,[N]=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,8.0,4.0,5.56,2.34,30.0061,-0.35,,34.14,0.0,1.0,0.0,0.0,,-2.9
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,3.0,7.16,3.02,341.426,0.22,-2.8,101.73,2.0,5.0,6.0,2.0,10.24,8.39
Levocarnitine,C[N+](C)(C)C[C@H](O)CC([O-])=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,1.0,0.4,1.67,0.63,161.1989,-4.9,-1.6,60.36,1.0,3.0,4.0,0.0,4.2,-3.6
Fenoprofen,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,7.0,3.0,6.79,2.85,242.2699,3.65,-3.5,46.53,1.0,2.0,4.0,2.0,3.96,-3.7
Reboxetine,[H][C@@]1(CNCCO1)[C@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,8.0,4.0,7.12,3.0,313.397,3.28,-4.2,39.72,1.0,4.0,6.0,3.0,,7.91
Sulfadiazine,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,10.0,4.0,8.95,3.78,250.277,0.39,-2.6,97.97,2.0,5.0,2.0,2.0,6.99,2.01
Betamethasone,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.13,0.89,392.4611,1.68,-3.9,94.83,3.0,5.0,2.0,4.0,12.42,-3.3
Fluticasone propionate,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.0,4.77,1.99,500.571,3.72,-4.6,80.67,1.0,4.0,6.0,4.0,13.61,-3.4
Thiethylperazine,CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.02,1.18,399.616,4.66,-4.9,9.72,0.0,3.0,6.0,4.0,,8.0
Betamethasone,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,1.5,4.72,1.98,392.4611,1.68,-3.9,94.83,3.0,5.0,2.0,4.0,12.42,-3.3
Fluticasone propionate,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,2.92,1.21,500.571,3.72,-4.6,80.67,1.0,4.0,6.0,4.0,13.61,-3.4
Indecainide,CC(C)NCCCC1(C(N)=O)C2=CC=CC=C2C2=CC=CC=C12,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.5,3.22,1.32,308.4174,3.26,-5.5,55.12,2.0,2.0,6.0,3.0,16.51,10.4
Asparagine,N[C@@H](CC(N)=O)C(O)=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,4.0,1.5,8.85,3.74,132.1179,-4.3,0.1,106.41,3.0,4.0,3.0,0.0,2.0,8.43
Indecainide,CC(C)NCCCC1(C(N)=O)C2=CC=CC=C2C2=CC=CC=C12,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,5.0,2.0,5.42,2.26,308.4174,3.26,-5.5,55.12,2.0,2.0,6.0,3.0,16.51,10.4
